var title_f43_23_44400="Massive cerebral air embolism";
var content_f43_23_44400=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Massive cerebral air embolism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 269px; height: 381px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gas is present throughout both hemispheres, and there is evidence of diffuse cerebral edema.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Valentino, R, Hilbert, G, Vargas, F, Gruson, D. Computed tomographic scan of massive cerebral air embolism. Lancet 2003; 361:1848. Copyright &copy; 2003 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44400=[""].join("\n");
var outline_f43_23_44400=null;
var title_f43_23_44401="Gram stain urine 3 with answer";
var content_f43_23_44401=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F58728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F58728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Staphylococcus saprophyticus in urine: Gram stain",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gram stain of unspun urine (x1000) shows inflammatory cells and Gram positive cocci in pairs and clusters. Staphylococcus saprophyticus grew from this specimen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44401=[""].join("\n");
var outline_f43_23_44401=null;
var title_f43_23_44402="Patient information: Lumbar puncture (spinal tap) (The Basics)";
var content_f43_23_44402=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/87111\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/49/29459\">",
"         Subarachnoid hemorrhage",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/13/26835\">",
"          Lumbar puncture",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?16/35/16946\">",
"         Patient information: Aseptic meningitis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?31/1/31762\">",
"         Patient information: Bacterial meningitis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/6/36962\">",
"         Patient information: Fungal meningitis and septic arthritis outbreak (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?43/9/44177\">",
"         Patient information: Hydrocephalus (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?37/51/38706\">",
"         Patient information: Idiopathic intracranial hypertension (pseudotumor cerebri) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?3/43/3763\">",
"         Patient information: Meningitis in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?29/19/30002\">",
"         Patient information: Subarachnoid hemorrhage (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/34/28194\">",
"         Patient information: Viral meningitis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?1/48/1796\">",
"         Patient information: Meningitis in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Lumbar puncture (spinal tap) (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H14930870\">",
"      <span class=\"h1\">",
"       What is a lumbar puncture?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A lumbar puncture, also called an &ldquo;LP,&rdquo; or a &ldquo;spinal tap,&rdquo; is a procedure doctors use to get a sample of fluid from around the spinal cord. The spinal cord is a bundle of nerves that runs from the base of the brain down the back. Both the brain and spinal cord are surrounded by fluid called &ldquo;cerebrospinal fluid.\" This fluid, also called &ldquo;CSF,&rdquo; cushions and protects the brain and spinal cord. This fluid can hold important clues about the health of the brain and spinal cord. It can show, for example, if there is infection or bleeding in the brain.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14930885\">",
"      <span class=\"h1\">",
"       Why might my doctor order an LP?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor might order an LP to check for problems that affect the brain or spinal cord. Some examples of these problems include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        An infection that affects the brain or spinal cord, such as meningitis",
"       </li>",
"       <li>",
"        Bleeding in a part of your head called the &ldquo;subarachnoid space&rdquo; &ndash; This is the area between your brain and the thin layer of tissue that covers it (",
"        <a class=\"graphic graphic_figure graphicRef61435 \" href=\"mobipreview.htm?28/49/29459\">",
"         figure 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        A condition called multiple sclerosis, which causes vision problems, numbness and tingling, muscle weakness, and other problems",
"       </li>",
"       <li>",
"        Cancer that has spread to the tissues surrounding the brain or spinal cord",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Doctors sometimes also do LPs to give certain types of medicines directly into the area surrounding the spinal cord. Examples of medicines that might be given this way include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Anesthesia (to block pain, for example during childbirth or surgery)",
"       </li>",
"       <li>",
"        Cancer-fighting medicines (called chemotherapy)",
"       </li>",
"       <li>",
"        Antibiotics",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14930929\">",
"      <span class=\"h1\">",
"       What happens during an LP?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Before having an LP, tell your doctor if you take",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?6/12/6342?source=see_link\">",
"       aspirin",
"      </a>",
"      or a medicine called",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/2/33830?source=see_link\">",
"       warfarin",
"      </a>",
"      (brand name: Coumadin). These medicines could increase your risk of bleeding during the procedure. It&rsquo;s important for the doctor to know if you take them. He or she will also test your blood to make sure that your blood clots normally.",
"     </p>",
"     <p>",
"      To get you ready for the LP, the doctor will probably ask you to lie on your side and hug your legs, so that your back is curved in a &ldquo;C&rdquo; shape. During the procedure, it is very important that you stay very still. Tell your doctor if you are uncomfortable or do not think you can stay still in the position he or she asks you to stay in.",
"     </p>",
"     <p>",
"      After you are in the right position, the doctor will clean the area around your lower back. He or she might also give you a shot to numb your lower back. Then the doctor will gently insert a needle into your back, between two of the bones (called &ldquo;vertebrae&rdquo;) that make up the spine. The needle will go straight through your skin and the tissues that surround the spinal cord into the space that is filled with fluid. The procedure is done in the lower part of the back below the point where the spinal cord ends (",
"      <a class=\"graphic graphic_figure graphicRef87112 \" href=\"mobipreview.htm?26/13/26835\">",
"       figure 2",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      After the doing the LP, your doctor might ask you to stay lying down for a half-hour or more, before you get up.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14930963\">",
"      <span class=\"h1\">",
"       What are the downsides of having an LP?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After having an LP, people can sometimes get a bad headache. This happens because the spot where the LP needle goes in does not always close up right away. If the hole stays open, CSF can leak out. That reduces the amount of cushioning around the brain, causing a headache.",
"     </p>",
"     <p>",
"      In most cases, the hole closes up on its own and the headache goes away in 1 to 2 days. If you get a headache after having an LP, you can take pain medicines to deal with it. The headache will also probably feel much better if you lie down. If your headache does not get better after 1 or 2 days, your doctors can offer you a treatment called a &ldquo;blood patch.&rdquo; This involves taking a small amount of blood and injecting it into the area where the LP was taken. The blood fills in the hole and CSF levels go back to normal, so the headache goes away.",
"     </p>",
"     <p>",
"      Rare problems caused by LP can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Infection",
"       </li>",
"       <li>",
"        Bleeding",
"       </li>",
"       <li>",
"        A life-threatening problem with the brain called &ldquo;cerebral herniation&rdquo; &ndash; This problem is very rare and usually happens only to people who already have a life-threatening brain condition.",
"       </li>",
"       <li>",
"        Pain or numbness in the back or legs",
"       </li>",
"       <li>",
"        Abnormal growths (called &ldquo;epidermoid tumors&rdquo;) that form on the spine long after the LP is done &ndash; These is more likely to happen in children than adults.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14930980\">",
"      <span class=\"h1\">",
"       What if my child needs an LP?",
"      </span>",
"      &nbsp;&mdash;&nbsp;LPs in children are very similar to LPs in adults, but children often must be given medicines to make them go to sleep before they have an LP. That&rsquo;s because children usually can&rsquo;t stay still the way they need to for an LP to be done the right way.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14930995\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?31/1/31762?source=see_link\">",
"       Patient information: Bacterial meningitis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/35/16946?source=see_link\">",
"       Patient information: Aseptic meningitis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/34/28194?source=see_link\">",
"       Patient information: Viral meningitis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/43/3763?source=see_link\">",
"       Patient information: Meningitis in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/51/38706?source=see_link\">",
"       Patient information: Idiopathic intracranial hypertension (pseudotumor cerebri) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?43/9/44177?source=see_link\">",
"       Patient information: Hydrocephalus (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/19/30002?source=see_link\">",
"       Patient information: Subarachnoid hemorrhage (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/6/36962?source=see_link\">",
"       Patient information: Fungal meningitis and septic arthritis outbreak (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/48/1796?source=see_link\">",
"       Patient information: Meningitis in children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?43/23/44402?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87111 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.65.66-BC5B390E05-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44402=[""].join("\n");
var outline_f43_23_44402=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14930870\">",
"      What is a lumbar puncture?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14930885\">",
"      Why might my doctor order an LP?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14930929\">",
"      What happens during an LP?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14930963\">",
"      What are the downsides of having an LP?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14930980\">",
"      What if my child needs an LP?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14930995\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/87111\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/49/29459\">",
"      Subarachnoid hemorrhage",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/13/26835\">",
"       Lumbar puncture",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/35/16946?source=related_link\">",
"      Patient information: Aseptic meningitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?31/1/31762?source=related_link\">",
"      Patient information: Bacterial meningitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/6/36962?source=related_link\">",
"      Patient information: Fungal meningitis and septic arthritis outbreak (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?43/9/44177?source=related_link\">",
"      Patient information: Hydrocephalus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/51/38706?source=related_link\">",
"      Patient information: Idiopathic intracranial hypertension (pseudotumor cerebri) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/48/1796?source=related_link\">",
"      Patient information: Meningitis in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/43/3763?source=related_link\">",
"      Patient information: Meningitis in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/19/30002?source=related_link\">",
"      Patient information: Subarachnoid hemorrhage (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/34/28194?source=related_link\">",
"      Patient information: Viral meningitis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_23_44403="Ultrasound image of abnormal axillary lymph node";
var content_f43_23_44403=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F82343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F82343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ultrasound image of abnormal axillary lymph node",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 355px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasound of abnormal axillary lymph node. The arrow indicates nodular thickening of the cortex of the lymph node.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44403=[""].join("\n");
var outline_f43_23_44403=null;
var title_f43_23_44404="Trastuzumab: Patient drug information";
var content_f43_23_44404=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Trastuzumab: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/39/6776?source=see_link\">",
"     see \"Trastuzumab: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F230142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Herceptin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F230143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Herceptin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10023233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700525",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Some patients have very bad side effects during the infusion. Tell your doctor if you have any bad effects during the infusion.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3733762",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause harm to your heart. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700735",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause lung problems. Closely read the part in this leaflet which lists when to call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10023235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691765",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat breast cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692098",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat stomach cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10023234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703063",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to trastuzumab or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701035",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to mouse proteins, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10023239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698509",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have a heart function test. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10023240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698316",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Runny nose.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10023242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698666",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10023237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10023244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11280 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-7B7E1375F2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44404=[""].join("\n");
var outline_f43_23_44404=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230142\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230143\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023233\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023235\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023234\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023239\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023240\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023242\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023237\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023244\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?6/39/6776?source=related_link\">",
"      Trastuzumab: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_23_44405="LV free wall rupture post MI";
var content_f43_23_44405=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left ventricular free wall rupture after MI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pathologic specimen showing free wall rupture (arrow) and hemopericardium after a myocardial infarction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Edwards, WD, Applied anatomy of the heart. In: Cardiology: Fundamentals and Practice, Brandenburg, RO, Fuster, V, Guiliani, ER, McGoon, DC (Eds), Year Book, Chicago, 1987, pp. 47-109.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44405=[""].join("\n");
var outline_f43_23_44405=null;
var title_f43_23_44406="Localization of the CDP and measurement of DL on EPT plot";
var content_f43_23_44406=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F86108&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F86108&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 624px\">",
"   <div class=\"ttl\">",
"    Localization of the contractile deceleration point (CDP) and measurement of distal latency (DL) on an esophageal pressure topography plot",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 604px; height: 464px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Physiologically, the CDP is the landmark in the distal esophagus where bolus transport transitions from peristalsis to the globular phrenic ampulla (note the conformation of the ampulla distal to the CDP in the fluoroscopy inset). On the pressure topography plot, the CDP is localized by the intersection of tangents drawn to the 30 mmHg isobaric contour (black line) for the early and late phases of the contraction. Note that for the early phase of the contraction (peristalsis), the slope of the tangent is the CFV, indicative of the propagation velocity of peristalsis. The DL, a measure of whether or not the distal esophageal contraction is timely or premature, is measured as the interval between UES relaxation and the CDP, with 4.5 seconds being the lower limit of normal.",
"    <div class=\"footnotes\">",
"     UES: upper esophageal sphincter; CDP: contractile deceleration point; CFV: contractile front velocity; EGJ: esophagogastric junction; S: second; DL: distal latency.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44406=[""].join("\n");
var outline_f43_23_44406=null;
var title_f43_23_44407="Prune-belly syndrome";
var content_f43_23_44407=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prune-belly syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/23/44407/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44407/contributors\">",
"     Manfred Wallner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44407/contributors\">",
"     Reinhard Kramar, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/23/44407/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44407/contributors\">",
"     F Bruder Stapleton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44407/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44407/contributors\">",
"     Laurence S Baskin, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/23/44407/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44407/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/23/44407/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prune-belly (Eagle-Barrett) syndrome (PBS) is a congenital disorder defined by a characteristic clinical triad (",
"    <a class=\"graphic graphic_picture graphicRef68993 \" href=\"mobipreview.htm?2/60/3011\">",
"     picture 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abdominal muscle deficiency",
"     </li>",
"     <li>",
"      Severe urinary tract abnormalities",
"     </li>",
"     <li>",
"      Bilateral cryptorchidism in males",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The term \"prune-belly\" reflects the characteristic wrinkled appearance of the abdominal wall in the newborn due to the complete or partially complete absence of abdominal wall muscles. In adolescent and adult life, the abdomen often assumes a smooth \"pot belly\" configuration.",
"   </p>",
"   <p>",
"    The Prune-belly syndrome including its pathology, clinical manifestations, diagnosis, management, and prognosis will be reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon data from the Kids' Inpatient Database from 2002, 2003, and 2006, the incidence of PBS in the United States was about 3.8 cases per 100,000 live births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/1\">",
"     1",
"    </a>",
"    ]. In this report, about 50 percent of affected patients were white, 30 percent black, and 10 percent Hispanic. PBS primarily occurs in males, although there are rare case reports of this disorder in females [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The genetic basis of PBS remains unknown. A recessive X-linked defect is suggested by the predominance of affected males. However, this mode of inheritance is precluded by two observations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Although rare, the disorder can occur in females [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Affected men suffer from azoospermia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PBS has also occurred in association with other chromosomal abnormalities, including trisomy 13, 18, and 21 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/3\">",
"     3",
"    </a>",
"    ], and a report of large deletion in the long arm of chromosome 6 in a male fetus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further evidence for a genetic basis of PBS includes a report of two cases of concordant prune belly syndrome in monozygotic twins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/5\">",
"     5",
"    </a>",
"    ], and a report of two nontwin brothers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Isolated abdominal wall muscular hypoplasia, without evidence of urinary tract or renal pathology, has also been described in a family with apparent autosomal dominant or mitochondrial inheritance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Mesenchymal developmental defect",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been suggested that the underlying defect in PBS is abnormal mesoderm development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. In particular, a primary defect in the intermediate and lateral plate mesoderm would affect embryogenesis of the musculature of the abdominal wall, the mesonephric and paramesonephric ducts, and the urinary organs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The underlying mesenchymal defect may be caused by a deletion of the hepatocyte nuclear factor 1 beta (HFN-1beta) gene on chromosome 17q12 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. HFN-1 beta is a transcription factor that regulates gene expression and plays a crucial role in embryonic development, as it is essential for visceral endoderm specification [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/12\">",
"     12",
"    </a>",
"    ]. HFN-1beta is expressed in the epithelial cells of the kidney, pancreas, liver, genital tract, and intestinal tract [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/13\">",
"     13",
"    </a>",
"    ]. Mutations in the HFN-1 beta gene may lead to abnormal development of the kidneys and genital tract; however, it does not explain all the findings of PBS, such as the lack of abdominal musculature.",
"   </p>",
"   <p>",
"    Alternatively, some investigators have suggested that early urethral obstruction by a valve-like mechanism is the primary abnormality in PBS, which can then lead to the other clinical manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. However, the observation that patients with congenital posterior urethral valves do not have the other features of PBS casts doubt on this hypothesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic involvement of the kidneys, genitourinary tract, and other organ systems result in the variable clinical manifestations of PBS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Kidneys",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major renal change in PBS is dysplasia that affects a variable portion of renal tissue. The dysplasia is manifested by incomplete nephron differentiation and dilatation of tubules, which are lined by immature epithelial cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/16\">",
"     16",
"    </a>",
"    ]. Tubular atrophy, interstitial fibrosis, and chronic lymphoplasmocytic infiltrates are present, and glomerulosclerosis is eventually seen. In addition, associated findings include reflux nephropathy and recurrent pyelonephritis, which may result in cortical scars.",
"   </p>",
"   <p>",
"    Renal dysplastic changes may not be evident before 16 weeks gestation as demonstrated by a case report from Japan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/17\">",
"     17",
"    </a>",
"    ]. In this report, a fetus was diagnosed with PBS by ultrasound at 12 weeks gestation with cystomegaly due to urethral obstruction. The pregnancy was terminated at 14 weeks gestation based upon fetal urinary electrolyte and beta-2-microglobulin values that indicated a poor renal prognosis. An autopsy demonstrated abdominal wall defects and severe urethral obstruction consistent with a diagnosis of PBS, but the kidneys were histologically normal without any evidence of dysplasia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Genitourinary tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities of the ureter, prostate, bladder, and testicles are commonly observed. These anomalies may be unilateral or bilateral, thereby resulting in varying degrees of renal insufficiency due to vesicoureteral reflux and obstruction.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ureters &mdash; The ureters are grossly elongated, dilated, and tortuous due to replacement of smooth muscle with fibrous tissue. Ureteral stenoses may occur due to kinking. Peristalsis is ineffective or lacking.",
"     </li>",
"     <li>",
"      Bladder &mdash; The bladder is usually enlarged and nontrabeculated, and has thickened walls (due to collagen deposits) with smooth muscle hypoplasia. The dome of the bladder is frequently capped by a diverticular remnant of the urachus. The trigone is barely discernible, and the ureteral ostia are lateralized (often with a golf-hole-like appearance).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Contrary to a widely held belief that urinary obstruction is the cause of bladder distention, intraluminal storage and voiding pressures are abnormally low in patients with PBS. Significant residual urine volumes suggest the presence of defective bladder urodynamics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prostate &mdash; A hallmark of PBS in males is a markedly hypoplastic or dysplastic prostate, which leads to dilatation of the prostatic urethra. In occasional patients, a valve-like mechanism develops in the membranous part of the urethra and causes urinary obstruction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/15\">",
"       15",
"      </a>",
"      ]. This may lead to a pressure-induced dysplasia of the prostate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Testicles &mdash; Bilateral undescended testes and an empty scrotum are regularly found in affected male patients. However, spermatogonia are not universally absent. The germ cells are markedly reduced in number, appear atypical, and may predispose to malignant tumors later in life [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Abdominal wall and gastrointestinal tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;A constant feature of PBS is partial aplasia or hypoplasia of the abdominal muscles (which may be unilateral or asymmetric), leading to the prune-belly appearance (",
"    <a class=\"graphic graphic_picture graphicRef68993 \" href=\"mobipreview.htm?2/60/3011\">",
"     picture 1",
"    </a>",
"    ). Electron microscopy of affected abdominal muscles reveals dystrophy with loss of coherence in the Z bands, clumping of glycogen granules, and mitochondrial abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastrointestinal malformations can occur and include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Malrotation of the midgut and persistence of the embryonic wide mesentery, resulting in coecum mobile, elongation of the colon, and volvulus. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/48/20232?source=see_link\">",
"       \"Intestinal malrotation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hindgut abnormalities, leading to anorectal malformations (eg, persistence of the embryonic cloaca, agenesis of rectum and anus).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Skeleton",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skeletal abnormalities are numerous and include clubfoot, dislocated hip, kyphoscoliosis, polydactyly, torticollis, and pectus excavatum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/23\">",
"     23",
"    </a>",
"    ]. Some of these abnormalities are deformations due to severe reduction of amniotic fluid (oligohydramnios). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/29/7639?source=see_link\">",
"     \"Lower extremity positional deformations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Lung",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung hypoplasia leading to respiratory insufficiency is frequently responsible for early mortality among patients with PBS. In the first half of gestation, oligohydramnios due to lack of sufficient urine production promotes mechanical compression of the fetus and inhibits thoracic expansion. Without amniotic fluid entering the airways, the lungs remain hypoplastic. In addition, thoracic cage deformities and paradoxical movement of the abdomen during respiration may predispose affected patients to mechanical restriction, thereby explaining their susceptibility to recurrent bronchitis and respiratory depression following anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, cases of congenital cystic adenomatoid malformations in patients with PBS have been reported, suggesting a possible association between these two disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/50/810?source=see_link\">",
"     \"Congenital pulmonary airway (cystic adenomatoid) malformation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Heart",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, complex cardiac anomalies can occur in association with PBS. In a single case report, isolated dextrocardia, single ventricle, pulmonary atresia, incomplete A-V septal defect, hemiazygos continuity, persistent right superior vena cava, and patent ductus arteriosus were described in an 11-month-old male infant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The severity of renal dysplasia and urinary tract abnormalities, and the presence of pulmonary hypoplasia are the two principal characteristics which determine the clinical manifestations and eventual outcome among patients with PBS. These abnormalities may result in recurrent episodes of urinary tract infections, urosepsis, varying degrees of renal and respiratory insufficiency, and other manifestations of the disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Renal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one-half of the patients surviving infancy will develop end-stage renal disease (ESRD) in childhood or adolescence. Findings of bilaterally abnormal kidneys (as determined by ultrasound or renal scan), a serum creatinine concentration greater than 0.7",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [62",
"    <span class=\"nowrap\">",
"     mcmol/L],",
"    </span>",
"    and episodes of clinical pyelonephritis appear to predict the eventual development of chronic renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/27\">",
"     27",
"    </a>",
"    ]. Other patients with the least severe form of the syndrome experience either no or only mild impairment of renal function.",
"   </p>",
"   <p>",
"    The severity and timing of onset of renal insufficiency may reflect the degree of renal dysplasia. One study, for example, correlated histologic findings with the severity and onset of renal insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/16\">",
"     16",
"    </a>",
"    ]. At autopsy, six of nine children who had died in infancy or as neonates had severe and diffuse renal dysplasia. By comparison, dysplastic changes were observed in less than 25 percent of the renal parenchyma in 10 surviving patients, all of whom had varying degrees of renal insufficiency. ESRD in these patients was thought to be due to pyelonephritis and obstruction, not renal dysplasia.",
"   </p>",
"   <p>",
"    There may be a striking discrepancy between the deformed appearance of the urinary tract on renal ultrasonography and voiding cystourethrogram, and the often surprisingly good renal function. These radiologic techniques are, therefore, not always reliable in assessing obstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Urogenital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent episodes of urinary tract infections and pyelonephritis, occasionally resulting in urosepsis, are common. In addition, although affected male patients usually experience normal erections and orgasm, retrograde ejaculation is frequent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/29\">",
"     29",
"    </a>",
"    ]. Despite early orchiopexy, there are case reports of successful paternity by aspirated sperm retrieval and in-vitro fertilization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Pulmonary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary and chest abnormalities may result in respiratory insufficiency, recurrent bronchitis, and respiratory depression following anesthesia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Other findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other findings include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic constipation is a common feature of PBS (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/63/15354?source=see_link\">",
"       \"Constipation in children: Etiology and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Impaired exercise tolerance in older children and adults due to paradoxical motion of the abdomen during respiration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Growth retardation occurs in up to one third of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/23\">",
"       23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Anorectal malformations have been described in children with PBS including imperforate anus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/31\">",
"       31",
"      </a>",
"      ], anorectal agenesis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/32\">",
"       32",
"      </a>",
"      ], or congenital pouch colon [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/33\">",
"       33",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of PBS may be made by antenatal ultrasonographic examination between weeks 20 and 30. High end vaginal sonography allows visualization of the kidneys and the urinary drainage system as early as 11 to 13 weeks of gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Striking features on ultrasound may include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bulging abdomen",
"     </li>",
"     <li>",
"      Lack of abdominal muscle wall (",
"      <a class=\"graphic graphic_picture graphicRef68993 \" href=\"mobipreview.htm?2/60/3011\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Dilatation of urinary bladder and ureters",
"     </li>",
"     <li>",
"      Hydronephrosis with or without echodense renal parenchyma",
"     </li>",
"     <li>",
"      Polycystic or dysplastic kidneys",
"     </li>",
"     <li>",
"      Oligohydramnios",
"     </li>",
"     <li>",
"      Fetal ascites",
"     </li>",
"     <li>",
"      Hypoplastic lungs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In some cases, it may be difficult to differentiate posterior urethral valves (PUV) from PBS as both may present with antenatal ultrasound findings of a dilated bladder and bilateral hydronephrosis. In the rare cases of in-utero intervention, patients with PBS have a better prognosis than those with PUV. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11271?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical presentation and diagnosis of posterior urethral valves\", section on 'Prenatal'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/41/36502?source=see_link&amp;anchor=H9#H9\">",
"     \"Management of posterior urethral valves\", section on 'Outcome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The syndrome is most often recognized at birth or in early childhood by the peculiar appearance of the abdominal wall, recurrent urinary tract infections, and varying degrees of renal insufficiency. PBS occasionally presents later in life as a rare cause of end-stage renal failure in the adult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Antenatal management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antenatal intervention may be required in severe cases of obstructive uropathy (ie, when mid-gestational oligohydramnios is present). In this setting, placement of a vesico-amniotic shunt may prevent an otherwise fatal neonatal course, due primarily to pulmonary hypoplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. In a series of 20 pregnancies with PBS, prenatal bladder shunting was performed with a one-year survival of in six of seven fetuses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/39\">",
"     39",
"    </a>",
"    ]. One-third of the surviving babies required dialysis and transplantation, and the majority had acceptable renal and bladder function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Postnatal management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The appropriate therapy of PBS in early childhood remains controversial. Severely affected patients require early surgery (supravesical diversion or primary reconstruction) to provide adequate urinary drainage and avoid recurrent infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/40\">",
"     40",
"    </a>",
"    ]. In some patients, the insertions of a cystostomy button may facilitate bladder drainage and improve quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By comparison, others may reach adult life with only a minor degree of chronic renal insufficiency, and, therefore, require only minimal early intervention. Furthermore, as the progression of the renal insufficiency in childhood and adolescence is primarily due to recurrent pyelonephritis and reflux nephropathy, adequate antibiotic therapy and, in rare cases, surgical intervention may prevent or delay end-stage renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/10/3242?source=see_link\">",
"     \"Presentation, diagnosis, and clinical course of vesicoureteral reflux\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     End-stage renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;For those with end-stage renal disease (ESRD), maintenance hemodialysis and continuous ambulatory peritoneal dialysis are equally effective in the management of end-stage renal disease in PBS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/42\">",
"     42",
"    </a>",
"    ]. In a small retrospective analysis of 14 children on peritoneal dialysis (five with PBS), the complication rates were not significantly different between the two groups despite the abdominal muscle defects of the PBS patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Renal transplantation has been successfully performed in PBS, with a usually excellent long-term outcome that is similar to other causes of end stage renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. However, extensive pretransplant urologic tract preparation may be necessary to reduce the postvoid residual volume to a minimum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There also may be rare complications of transplantation intrinsic to this syndrome, such as acute torsion of the transplant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/48\">",
"     48",
"    </a>",
"    ]. In some cases when the native bladder is unsuitable, successful drainage of the transplanted kidney into a urinary conduit or augmented bladder has been performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Other genitourinary interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional therapeutic interventions may also be required for other manifestations of the PBS. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reduction cystoplasty may help improve voiding and minimize infection, although bladder capacity is not reduced, and voiding dynamics are not improved [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Urethrotomy may often improve bladder emptying, even if there is no anatomical obstruction (\"functional obstruction\") [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The intraabdominal testes in males have been successfully brought to the scrotum laparoscopically or by a Fowler-Stephens orchiopexy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/52,53\">",
"       52,53",
"      </a>",
"      ]. This procedure should",
"      <strong>",
"       not",
"      </strong>",
"      be delayed until adolescence. In a retrospective series of 41 male adults with PBS who had undergone Fowler-Stephens orchiopexy in childhood, 38 (93 percent) achieved sufficient testicular function to induce puberty and maintain satisfactory sexual function in adult life [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/54\">",
"       54",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/44/17098?source=see_link\">",
"       \"Undescended testes (cryptorchidism) in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Abdominal wall reconstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The abdominal wall may be reconstructed for cosmetic and psychosocial reasons by excision of the redundant skin while preserving the umbilicus (Monfort procedure) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/55\">",
"     55",
"    </a>",
"    ]. In addition, this may improve bladder function, with reduction of post-void residual urine volume, as well as bowel function.",
"   </p>",
"   <p>",
"    In those who do not require a concurrent intraabdominal procedure, an abdominoplasty can be performed by an extraperitoneal plication of fascial folds, obviating the need for a fascial incision",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    entrance into the peritoneal cavity; this technique produces cosmetically excellent results with a decreased recovery time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/56\">",
"     56",
"    </a>",
"    ]. This reconstruction may be done by laparoscopy that potentially decreases morbidity and complications associated with an open surgical procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To improve the functional status of the abdominal wall, muscle transposition from the thigh musculature has been performed, which may prevent the loss of spinal stability and development of kyphoscoliosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/58,59\">",
"     58,59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Spinal procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;In rare cases of marked scoliotic spine deformities, orthopedic surgery is warranted to correct the underlying defect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the prune-belly syndrome have had a generally poor prognosis. In older reports, 20 percent of affected children were said to be stillborn, and 50 percent did not survive to the age of two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/61\">",
"     61",
"    </a>",
"    ]. However, early diagnosis and appropriate therapy can prolong survival. In a more recent series of 50 patients, the overall mortality was 32 percent, with the majority of deaths confined to the perinatal period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44407/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prune-belly (Eagle-Barrett) syndrome (PBS) is a congenital disorder defined by a characteristic clinical triad that includes abdominal muscle deficiency, severe urinary tract abnormalities, and bilateral cryptorchidism in males (",
"    <a class=\"graphic graphic_picture graphicRef68993 \" href=\"mobipreview.htm?2/60/3011\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The estimated incidence is 3.8 cases per 100,000 births. Boys are primarily affected, although there are rare cases in females. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathogenesis of PBS remains unknown. It is thought to be due to a mesenchymal genetic defect. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The severity of renal pathology is the primary factor that affects the clinical manifestations of PBS. Dysplasia is the main renal abnormality of PBS, and it is manifested by incomplete nephron differentiation and dilatation of the tubules. About one-half of patients have severe dysplasia and develop end-stage renal disease (ESRD) and require renal replacement therapy. In addition, insufficient fetal urine production leading to oligohydramnios results in pulmonary hypoplasia and neonatal mortality among patients with severe PBS. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Kidneys'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Renal'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Lung'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other clinical findings include genitourinary abnormalities including cryptorchidism in males, and aplasia or hypoplasia of the abdominal muscles. Less commonly, gastrointestinal malformations (eg, malrotation of the midgut or anorectal malformations), skeletal abnormalities (eg, clubfoot), and rarely cardiac anomalies are observed. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of PBS may be made by antenatal ultrasonographic examination between weeks 20 and 30 or at birth or in early childhood by clinical recognition of the syndrome. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of PBS is dependent upon the severity of the clinical findings.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In rare cases, antenatal intervention has been performed to reduce the risk and severity of pulmonary hypoplasia. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Antenatal management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postnatal surgical intervention may be needed to provide adequate urinary drainage and avoid urinary tract infections in some patients (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Postnatal management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Renal replacement therapy for those patients with ESRD includes dialysis and renal transplantation. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'End-stage renal disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other interventions include additional genitourinary procedures to improve bladder control and capacity, orchiopexy, abdominal wall reconstruction, and in rare cases, orthopedic surgery for skeletal deformities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although the survival rate has improved for PBS with earlier diagnosis and intervention, the mortality rate still remains about 30 percent, with the majority of deaths occurring in the perinatal period. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/1\">",
"      Routh JC, Huang L, Retik AB, Nelson CP. Contemporary epidemiology and characterization of newborn males with prune belly syndrome. Urology 2010; 76:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/2\">",
"      Reinberg Y, Shapiro E, Manivel JC, et al. Prune belly syndrome in females: a triad of abdominal musculature deficiency and anomalies of the urinary and genital systems. J Pediatr 1991; 118:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/3\">",
"      Amacker EA, Grass FS, Hickey DE, Hisley JC. An association of prune belly anomaly with trisomy 21. Am J Med Genet 1986; 23:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/4\">",
"      Fryns JP, Vandenberghe K, Van den Berghe H. Prune-belly anomaly and large interstitial deletion of the long arm of chromosome 6. Ann Genet 1991; 34:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/5\">",
"      Balaji KC, Patil A, Townes PL, et al. Concordant prune belly syndrome in monozygotic twins. Urology 2000; 55:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/6\">",
"      Ramasamy R, Haviland M, Woodard JR, Barone JG. Patterns of inheritance in familial prune belly syndrome. Urology 2005; 65:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/7\">",
"      Chan YC, Bird LM. Vertically transmitted hypoplasia of the abdominal wall musculature. Clin Dysmorphol 2004; 13:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/8\">",
"      Straub E, Spranger J. Etiology and pathogenesis of the prune belly syndrome. Kidney Int 1981; 20:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/9\">",
"      Stephens FD, Gupta D. Pathogenesis of the prune belly syndrome. J Urol 1994; 152:2328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/10\">",
"      Murray PJ, Thomas K, Mulgrew CJ, et al. Whole gene deletion of the hepatocyte nuclear factor-1beta gene in a patient with the prune-belly syndrome. Nephrol Dial Transplant 2008; 23:2412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/11\">",
"      Haeri S, Devers PL, Kaiser-Rogers KA, et al. Deletion of hepatocyte nuclear factor-1-beta in an infant with prune belly syndrome. Am J Perinatol 2010; 27:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/12\">",
"      Coffinier C, Th&eacute;pot D, Babinet C, et al. Essential role for the homeoprotein vHNF1/HNF1beta in visceral endoderm differentiation. Development 1999; 126:4785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/13\">",
"      Coffinier C, Barra J, Babinet C, Yaniv M. Expression of the vHNF1/HNF1beta homeoprotein gene during mouse organogenesis. Mech Dev 1999; 89:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/14\">",
"      Moerman P, Fryns JP, Goddeeris P, Lauweryns JM. Pathogenesis of the prune-belly syndrome: a functional urethral obstruction caused by prostatic hypoplasia. Pediatrics 1984; 73:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/15\">",
"      Hoagland MH, Hutchins GM. Obstructive lesions of the lower urinary tract in the prune belly syndrome. Arch Pathol Lab Med 1987; 111:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/16\">",
"      Reinberg Y, Manivel JC, Pettinato G, Gonzalez R. Development of renal failure in children with the prune belly syndrome. J Urol 1991; 145:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/17\">",
"      Shigeta M, Nagata M, Shimoyamada H, et al. Prune-belly syndrome diagnosed at 14 weeks' gestation with severe urethral obstruction but normal kidneys. Pediatr Nephrol 1999; 13:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/18\">",
"      Kinahan TJ, Churchill BM, McLorie GA, et al. The efficiency of bladder emptying in the prune belly syndrome. J Urol 1992; 148:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/19\">",
"      Volmar KE, Fritsch MK, Perlman EJ, Hutchins GM. Patterns of congenital lower urinary tract obstructive uropathy: relation to abnormal prostate and bladder development and the prune belly syndrome. Pediatr Dev Pathol 2001; 4:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/20\">",
"      Massad CA, Cohen MB, Kogan BA, Beckstead JH. Morphology and histochemistry of infant testes in the prune belly syndrome. J Urol 1991; 146:1598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/21\">",
"      Mininberg DT, Montoya F, Okada K, et al. Subcellular muscle studies in the prune belly syndrome. J Urol 1973; 109:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/22\">",
"      Wright JR Jr, Barth RF, Neff JC, et al. Gastrointestinal malformations associated with prune belly syndrome: three cases and a review of the literature. Pediatr Pathol 1986; 5:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/23\">",
"      Geary DF, MacLusky IB, Churchill BM, McLorie G. A broader spectrum of abnormalities in the prune belly syndrome. J Urol 1986; 135:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/24\">",
"      Ewig JM, Griscom NT, Wohl ME. The effect of the absence of abdominal muscles on pulmonary function and exercise. Am J Respir Crit Care Med 1996; 153:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/25\">",
"      Armstrong R, Fryer A, Pisipati S, Jesudason E. Evaluating the association between congenital cystic adenomatoid malformation of the lung and abdominal wall laxity. Clin Dysmorphol 2007; 16:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/26\">",
"      Do��an R, Yilmaz M, Duman U U, Ozkutlu S. Bidirectional Glenn shunt in an infant with prune-belly syndrome. Thorac Cardiovasc Surg 2001; 49:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/27\">",
"      Noh PH, Cooper CS, Winkler AC, et al. Prognostic factors for long-term renal function in boys with the prune-belly syndrome. J Urol 1999; 162:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/28\">",
"      Woodhouse CR, Kellett MJ, Williams DI. Minimal surgical interference in the prune belly syndrome. Br J Urol 1979; 51:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/29\">",
"      Woodhouse CR, Snyder HM 3rd. Testicular and sexual function in adults with prune belly syndrome. J Urol 1985; 133:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/30\">",
"      Kolettis PN, Ross JH, Kay R, Thomas AJ Jr. Sperm retrieval and intracytoplasmic sperm injection in patients with prune-belly syndrome. Fertil Steril 1999; 72:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/31\">",
"      Morgan CL Jr, Grossman H, Novak R. Imperforate anus and colon calcification in association with the prune belly syndrome. Pediatr Radiol 1978; 7:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/32\">",
"      Walker J, Prokurat AI, Irving IM. Prune belly syndrome associated with exomphalos and anorectal agenesis. J Pediatr Surg 1987; 22:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/33\">",
"      Bangroo AK, Tiwari S, Khetri R, Sahni M. Congenital pouch colon with prune belly syndrome and megalourethra. Pediatr Surg Int 2005; 21:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/34\">",
"      Yamamoto H, Nishikawa S, Hayashi T, et al. Antenatal diagnosis of prune belly syndrome at 11 weeks of gestation. J Obstet Gynaecol Res 2001; 27:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/35\">",
"      Wallner M, Kramar R. Detection of prune-belly syndrome in a 35-year-old man: a rare cause of end-stage renal failure in the adult. Am J Nephrol 1990; 10:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/36\">",
"      Brown PS Jr, Hartz RS, Hines JR. Prune belly syndrome in adult man. Urology 1993; 41:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/37\">",
"      Leeners B, Sauer I, Schefels J, et al. Prune-belly syndrome: therapeutic options including in utero placement of a vesicoamniotic shunt. J Clin Ultrasound 2000; 28:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/38\">",
"      Freedman AL, Johnson MP, Smith CA, et al. Long-term outcome in children after antenatal intervention for obstructive uropathies. Lancet 1999; 354:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/39\">",
"      Biard JM, Johnson MP, Carr MC, et al. Long-term outcomes in children treated by prenatal vesicoamniotic shunting for lower urinary tract obstruction. Obstet Gynecol 2005; 106:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/40\">",
"      Woodard JR, Zucker I. Current management of the dilated urinary tract in prune belly syndrome. Urol Clin North Am 1990; 17:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/41\">",
"      Milliken I, Munro NP, Subramaniam R. Cystostomy button for bladder drainage in children. J Urol 2007; 178:2604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/42\">",
"      Crompton CH, Balfe JW, Khoury A. Peritoneal dialysis in the prune belly syndrome. Perit Dial Int 1994; 14:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/43\">",
"      Wisanuyotin S, Dell KM, Vogt BA, et al. Complications of peritoneal dialysis in children with Eagle-Barrett syndrome. Pediatr Nephrol 2003; 18:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/44\">",
"      Fontaine E, Salomon L, Gagnadoux MF, et al. Long-term results of renal transplantation in children with the prune-belly syndrome. J Urol 1997; 158:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/45\">",
"      Fusaro F, Zanon GF, Ferreli AM, et al. Renal transplantation in prune-belly syndrome. Transpl Int 2004; 17:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/46\">",
"      Kamel MH, Thomas AA, Al-Mufarrej FM, et al. Deceased-donor kidney transplantation in prune belly syndrome. Urology 2007; 69:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/47\">",
"      Djakovic N, Wagener N, Adams J, et al. Intestinal reconstruction of the lower urinary tract as a prerequisite for renal transplantation. BJU Int 2009; 103:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/48\">",
"      Abbitt PL, Chevalier RL, Rodgers BM, Howards SS. Acute torsion of a renal transplant: cause of organ loss. Pediatr Nephrol 1990; 4:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/49\">",
"      Hatch DA, Koyle MA, Baskin LS, et al. Kidney transplantation in children with urinary diversion or bladder augmentation. J Urol 2001; 165:2265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/50\">",
"      Bukowski TP, Perlmutter AD. Reduction cystoplasty in the prune belly syndrome: a long-term followup. J Urol 1994; 152:2113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/51\">",
"      Woodhouse CR, Neild GH. A child with recurrent urine infections and undescended testes. Nephrol Dial Transplant 1995; 10:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/52\">",
"      Docimo SG, Moore RG, Kavoussi LR. Laparoscopic orchidopexy in the prune belly syndrome: a case report and review of the literature. Urology 1995; 45:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/53\">",
"      Redman JF, Mooney DK. Fowler-Stephens orchiopexy in a patient with prune belly syndrome and segmental atretic vas deferens. Urology 1993; 41:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/54\">",
"      Patil KK, Duffy PG, Woodhouse CR, Ransley PG. Long-term outcome of Fowler-Stephens orchiopexy in boys with prune-belly syndrome. J Urol 2004; 171:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/55\">",
"      Monfort G, Guys JM, Bocciardi A, et al. A novel technique for reconstruction of the abdominal wall in the prune belly syndrome. J Urol 1991; 146:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/56\">",
"      Furness PD 3rd, Cheng EY, Franco I, Firlit CF. The prune-belly syndrome: a new and simplified technique of abdominal wall reconstruction. J Urol 1998; 160:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/57\">",
"      Franco I. Laparoscopic assisted modification of the firlit abdominal wall plication. J Urol 2005; 174:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/58\">",
"      Ger R, Coryllos EV. Management of the abdominal wall defect in the prune belly syndrome by muscle transposition: an 18-year follow-up. Clin Anat 2000; 13:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/59\">",
"      Lam KS, Mehdian H. The importance of an intact abdominal musculature mechanism in maintaining spinal sagittal balance. Case illustration in prune-belly syndrome. Spine (Phila Pa 1976) 1999; 24:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/60\">",
"      Heini PF, Locher S, Schede CP, et al. Surgical treatment with the technique of Galveston-Luque of spine deformities associated with the prune belly syndrome. J Pediatr Orthop B 2004; 13:231.",
"     </a>",
"    </li>",
"    <li>",
"     Duckett JW. The prune belly syndrome. In: Clinical Pediatric Urology, Kelalis PP, King LR (Eds), Saunders, Philadelphia 1976.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44407/abstract/62\">",
"      Burbige KA, Amodio J, Berdon WE, et al. Prune belly syndrome: 35 years of experience. J Urol 1987; 137:86.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5002 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-47BF19C4B0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44407=[""].join("\n");
var outline_f43_23_44407=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Mesenchymal developmental defect",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Kidneys",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Genitourinary tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Abdominal wall and gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Skeleton",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Lung",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Heart",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Renal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Urogenital",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Pulmonary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Other findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Antenatal management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Postnatal management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - End-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Other genitourinary interventions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Abdominal wall reconstruction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Spinal procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5002\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5002|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/60/3011\" title=\"picture 1\">",
"      Prune belly syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11271?source=related_link\">",
"      Clinical presentation and diagnosis of posterior urethral valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/50/810?source=related_link\">",
"      Congenital pulmonary airway (cystic adenomatoid) malformation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/63/15354?source=related_link\">",
"      Constipation in children: Etiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/48/20232?source=related_link\">",
"      Intestinal malrotation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/29/7639?source=related_link\">",
"      Lower extremity positional deformations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/41/36502?source=related_link\">",
"      Management of posterior urethral valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/10/3242?source=related_link\">",
"      Presentation, diagnosis, and clinical course of vesicoureteral reflux",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/44/17098?source=related_link\">",
"      Undescended testes (cryptorchidism) in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_23_44408="Therapeutic use of fondaparinux";
var content_f43_23_44408=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Therapeutic use of fondaparinux",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/23/44408/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44408/contributors\">",
"     Kenneth A Bauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/23/44408/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44408/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/23/44408/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44408/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/23/44408/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    (Arixtra&reg;) is a synthetic, highly sulfated pentasaccharide, which has a sequence derived from the minimal antithrombin (AT) binding region of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       Fondaparinux",
"      </a>",
"      binds to AT with a higher affinity than the native pentasaccharide of unfractionated",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      or low molecular weight heparin, and causes a conformational change in AT that significantly increases the ability of AT to inactivate factor Xa. This is the basis of the ability of fondaparinux to serve as an anticoagulant.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       Fondaparinux",
"      </a>",
"      cannot bind to and inactivate thrombin (factor IIa). Such inactivation requires the formation of a ternary complex in which",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      binds to both AT and to a binding site on thrombin (",
"      <a class=\"graphic graphic_figure graphicRef64839 \" href=\"mobipreview.htm?35/16/36110\">",
"       figure 1",
"      </a>",
"      ). This complex forms only on pentasaccharide-containing chains at least 18 saccharide units long, chains that are less prevalent in low molecular weight heparin preparations and not at all present in fondaparinux [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/59/37818?source=see_link&amp;anchor=H4#H4\">",
"       \"Anticoagulants other than heparin and warfarin\", section on 'Thrombin as an anticoagulant target'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    as an anticoagulant will be reviewed here [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. A general discussion of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    -like anticoagulants and the use of such agents for the prevention",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatment of venous thromboembolism are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33930?source=see_link\">",
"     \"Therapeutic use of heparin and low molecular weight heparin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    binds to antithrombin with high affinity (dissociation constant 50 nmol) in a 1:1 stoichiometric and reversible manner [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. It does not bind to or interact with other plasma proteins or cellular elements. Specifically, fondaparinux does not interact with platelets or platelet factor 4, and thus, unlike",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , is not expected to induce thrombocytopenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40890?source=see_link&amp;anchor=H3#H3\">",
"     \"Heparin-induced thrombocytopenia\", section on 'Pathophysiology'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H20\">",
"     'Heparin induced thrombocytopenia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    is 100 percent bioavailable after subcutaneous (SQ) injection, with half-maximal and peak serum concentrations reached in 25 minutes and 1.7 hours following SQ injection, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/9\">",
"     9",
"    </a>",
"    ]. The half-life of this agent is much longer (mean 17 hours) than that of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    and low molecular weight heparins, allowing it to be given once daily.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Antidote",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    is not inactivated by protamine. No antidote is known, although high doses of recombinant factor VIIa (90",
"    <span class=\"nowrap\">",
"     micrograms/kg)",
"    </span>",
"    have been shown to partially normalize the prolonged aPTT, the endogenous thrombin potential, and prothrombin activation in vivo (as measured by prothrombin fragment F1+2 levels) in healthy volunteers given 10 mg of fondaparinux [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/10\">",
"     10",
"    </a>",
"    ] or 7.5 mg of idraparinux [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    General measures that should be taken in any patient with anticoagulant-associated severe bleeding are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/59/37818?source=see_link&amp;anchor=H32#H32\">",
"     \"Anticoagulants other than heparin and warfarin\", section on 'Emergency treatment of bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Drug monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    at prophylactic doses (ie, 2.5 mg) (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Dose range'",
"    </a>",
"    below) does not prolong the activated partial thromboplastin time (aPTT), prothrombin time, or bleeding time, or alter platelet function or fibrinolysis. There may be a slight prolongation of the aPTT when fondaparinux is given at therapeutic doses (ie, 7.5 to 10 mg) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/10\">",
"     10",
"    </a>",
"    ]. Monitoring can be achieved via an anti-factor Xa assay calibrated with fondaparinux [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Renal clearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of an administered dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    is cleared by the kidney, and excreted unchanged in the urine, with an elimination half-life of 15 to 17 hours. Clearance of this drug is reduced in subjects with reduced creatinine clearance; fondaparinux was not given to patients in phase II or III studies who had serum creatinine levels &gt;1.8",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Dose range",
"    </span>",
"    &nbsp;&mdash;&nbsp;In",
"    a dose-ranging trial for the prevention of VTE in patients undergoing total hip replacement, a high incidence of major bleeding episodes led to discontinuation of the 6 and 8",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/4\">",
"     4",
"    </a>",
"    ]. A dose of 3",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    SQ demonstrated a significantly lower rate of venous thromboembolism than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    , with a similar rate of major bleeding. In all of the phase III trials to be described below, the dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    was 2.5",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    SQ, starting six hours postoperatively.",
"   </p>",
"   <p>",
"    When used for initial treatment of VTE, the dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    has ranged from 5 to 10 mg SQ once daily, depending upon the patient's body weight (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Initial treatment of venous thromboembolism'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    The safety and efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    have not been established in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Longer-acting analogues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Longer-acting analogues of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    (idraparinux, idrabiotaparinux), able to be given SQ only once per week, have been evaluated in clinical trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/13-17\">",
"     13-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one randomized study, idraparinux was found to be noninferior to standard therapy in patients with deep vein thrombosis, but was inferior to standard therapy in patients with pulmonary emboli [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A second randomized trial evaluated six months of extended prophylaxis with idraparinux or placebo in 1215 patients with symptomatic VTE who had completed six months of anticoagulant therapy with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/63/11256?source=see_link\">",
"       acenocoumarol",
"      </a>",
"      , or idraparinux. Extended prophylaxis with idraparinux prevented recurrence of VTE in the following six months, but increased the risk of major bleeding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A third randomized trial, comparing idraparinux to adjusted dose vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation was stopped early due to a significantly increased incidence of clinically relevant bleeding with idraparinux (19.7 versus 11.3 events per 100 patient-years) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/17\">",
"       17",
"      </a>",
"      ]. However, idraparinux was not inferior to vitamin K antagonists in terms of the primary efficacy outcome of all strokes and systemic embolism (hazard ratio 0.71; 95% CI 0.39-1.30).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of this concern of excessive bleeding, the development of idraparinux has been halted and a biotinylated version (idrabiotaparinux), capable of being neutralized by intravenous infusion of avidin in the case of excessive bleeding, continues in development for the treatment of VTE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/59/37818?source=see_link&amp;anchor=H17#H17\">",
"     \"Anticoagulants other than heparin and warfarin\", section on 'Idrabiotaparinux'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Platelet count monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of inducing a syndrome resembling immune",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    -induced thrombocytopenia (HIT) with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    appears to be much lower than that seen with low molecular weight heparin, and may be negligible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/20\">",
"     20",
"    </a>",
"    ]. Accordingly, it has been recommended that clinicians not use routine platelet count monitoring for patients receiving fondaparinux [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PREVENTION OF POSTOPERATIVE VTE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized phase III trials have shown that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    started four to eight hours postoperatively had superior efficacy in preventing venous thromboembolism (VTE), as judged by a composite endpoint of bilateral ascending venography and objectively documented symptomatic endpoints, compared with low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    ) following elective orthopedic surgery (total hip replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/9,22\">",
"     9,22",
"    </a>",
"    ], total knee replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/23\">",
"     23",
"    </a>",
"    ] and hip fracture surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/24\">",
"     24",
"    </a>",
"    ]). Fondaparinux was also shown to be non-inferior to the low molecular weight heparin",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/56/32648?source=see_link\">",
"     dalteparin",
"    </a>",
"    in preventing postoperative VTE in patients undergoing high-risk abdominal surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/25\">",
"     25",
"    </a>",
"    ]. These studies are reviewed below.",
"   </p>",
"   <p>",
"    A meta-analysis of four multicenter, randomized, double-blind trials for the prevention of VTE after major orthopedic surgery, in which",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    was administered at a dose of 2.5",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    (a dose considered to be optimal), with therapy beginning four to eight hours after surgery, concluded the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      , as compared with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"       enoxaparin",
"      </a>",
"      , was associated with a significantly reduced risk of VTE by day 11 (6.8 versus 13.7 percent, common odds reduction: 55 percent, 95% CI: 46-63 percent).",
"     </li>",
"     <li>",
"      Use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      , as compared with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"       enoxaparin",
"      </a>",
"      , was associated with a significant increase in the risk of major bleeding (2.7 versus 1.7 percent). The difference in rates of major bleeding was attributable to an increase in cases as judged by the \"bleeding index\", namely any report of overt bleeding in association with a drop in hemoglobin of &ge;2",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      or the transfusion of &ge;2 units of blood (2.3 versus 1.5 percent, respectively). There were no significant differences between the two groups in the incidence of clinically relevant bleeding (eg, fatal bleeding, bleeding in a critical organ, or bleeding requiring reoperation; 0.3 percent in both).",
"     </li>",
"     <li>",
"      No episodes of severe thrombocytopenia were reported following use of either agent in any of the four studies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a post-hoc efficacy and safety analysis, the incidence of major bleeding was significantly less (2.1 versus 3.2 percent) in those patients receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    &ge;6 versus &lt;6 hours following skin closure, respectively; there was no significant difference in efficacy (ie, the risk of VTE) when fondaparinux was given at these two different time points (7.0 versus 6.4 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/27\">",
"     27",
"    </a>",
"    ]. This finding was responsible for the regulatory agency recommendation for the timing of fondaparinux (ie, six to eight hours following achievement of hemostasis), rather than the timing in the original randomized studies (ie, four to eight hours following surgery).",
"   </p>",
"   <p>",
"    In a review of individual data on 13,085 patients from eight large randomized trial of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    for the prevention of VTE in medical or surgical patients, the following information was obtained concerning the risk of major bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/28\">",
"     28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In these trials, the risk of major bleeding was significantly increased in those who were older, male, had lower body weight or lower creatinine clearance, or received",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      At 30 days, the risk of death was sevenfold higher among patients with a major bleeding event (8.6 versus 1.7 percent, HR 6.96; 95% CI 4.6-10.5).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following sections illustrate the results of controlled trials in specific clinical settings. The superior efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    in preventing VTE may have been due, in part, to starting fondaparinux earlier in the postoperative period (four to eight hours) than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    (12 to 24 hours).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Total hip replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;One phase II [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/4\">",
"     4",
"    </a>",
"    ] and two phase III trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/9,22\">",
"     9,22",
"    </a>",
"    ] have been completed in which",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    , in doses ranging from 2.5 to 3",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    SQ, starting four to eight hours postoperatively, was compared with 30 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    SQ every 12 hours starting 12 to 24 hours postoperatively (PENTATHLON trial) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/4,22\">",
"     4,22",
"    </a>",
"    ], or with 40 mg of enoxaparin given 12 hours before surgery, followed by 40 mg 12 to 24 hours after surgery and daily thereafter (EPHESUS trial) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/9\">",
"     9",
"    </a>",
"    ]. In all three studies, fondaparinux was more effective than enoxaparin in preventing postoperative VTE, with relative risk reductions in the phase II and III trials ranging from 26 to 81 percent. Rates of major bleeding ranged from 1.8 to 4.1 percent for fondaparinux and 1.0 to 3.5 percent for enoxaparin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hip fracture surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a phase III trial, patients undergoing surgery for fracture of the upper third of the femur were randomly assigned to treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    (2.5 mg once daily starting four to eight hours postoperatively) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    (40",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    starting 12 hours preoperatively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/24\">",
"     24",
"    </a>",
"    ]. The incidence of VTE by day 11 was significantly lower with fondaparinux (8.3 versus 19.1 percent). There were no significant differences in the incidence of death or major bleeding.",
"   </p>",
"   <p>",
"    The benefit of thromboprophylaxis with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    for one month, rather than one week was studied in a double-blind, multicenter trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/29\">",
"     29",
"    </a>",
"    ]. All patients received fondaparinux for the first six to eight days, following which they were randomly assigned to receive fondaparinux (2.5",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or placebo for an additional 19 to 23 days. Compared with one week of fondaparinux (followed by three weeks of placebo), one month of fondaparinux resulted in a highly significant reduction in the incidence of documented VTE from 35 to 1.4 percent (relative risk reduction 96 percent, 95% CI: 87-100 percent), as well as an 87 percent reduction in the risk of symptomatic VTE. Although there was a non-significant trend toward more major bleeding in the group treated with one month of fondaparinux, as judged by the bleeding index, there were no differences between the two groups in the incidence of bleeding into critical organs, or bleeding leading to death or reoperation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Knee surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a phase III trial, patients undergoing major knee surgery were randomly assigned to treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    (2.5 mg once daily starting four to eight hours after surgery) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    (30 mg twice daily starting 12 to 24 hours after surgery) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/23\">",
"     23",
"    </a>",
"    ]. The incidence of VTE by day 11 was significantly lower with fondaparinux (12.5 versus 27.8 percent). Major bleeding occurred more frequently in the fondaparinux group, as judged by the \"bleeding index\" (see above), but there were no significant differences between the two groups in the incidence of clinically relevant bleeding (eg, fatal bleeding, bleeding in a critical organ, or bleeding requiring reoperation).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Abdominal surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the double-blind randomized PEGASUS trial, patients scheduled for major abdominal surgery under general anesthesia were randomly assigned to one of the following two treatments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/25\">",
"     25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       Fondaparinux",
"      </a>",
"      (2.5 mg SQ daily for five to nine days, starting six hours after surgery), or",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/56/32648?source=see_link\">",
"       Dalteparin",
"      </a>",
"      (2500 units SQ two hours before surgery and 12 hours after the preoperative administration, followed by 5000 units SQ daily for five to nine days)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among 2048 evaluable patients, the rate of VTE for those treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/56/32648?source=see_link\">",
"     dalteparin",
"    </a>",
"    was 4.6 versus 6.1 percent, respectively, for a relative risk reduction of 25 percent (95% CI -9 to +48), meeting the predetermined criterion for non-inferiority of fondaparinux. Major bleeding was similar in the two treatment arms (3.4 versus 2.4 percent, respectively).",
"   </p>",
"   <p>",
"    In the APOLLO Study, patients age &ge;40 undergoing major abdominal surgery of at least 45 minutes duration were randomly assigned to receive postoperative VTE prevention with intermittent pneumatic compression plus either placebo or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    (2.5 mg once daily SQ for five to nine days, starting six to eight hours postoperatively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/30\">",
"     30",
"    </a>",
"    ]. The vast majority (82 percent) of the subjects had at least one VTE risk factor over and above their age and the abdominal surgery. Fondaparinux significantly reduced the VTE rate versus that seen after placebo (1.7 versus 5.3 percent; odds ratio reduction 70 percent, 95% CI 28-87).",
"   </p>",
"   <p>",
"    Major bleeding was more frequent after",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    (1.6 versus 0.2 percent), although none of the bleeding events were fatal or involved a critical organ.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT OF VENOUS THROMBOEMBOLISM",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Pulmonary embolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy and safety of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    as initial treatment of acute symptomatic pulmonary embolism was compared with that of unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    in an open-label trial involving 2213 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/31\">",
"     31",
"    </a>",
"    ]. Patients were randomly assigned to receive either fondaparinux once daily (5, 7.5, or 10 mg SQ for those weighing &lt;50, 50 to 100, or &gt;100 kg, respectively) without monitoring, or a continuous IV infusion of unfractionated heparin (to achieve a ratio of the patient's aPTT to control of 1.5 to 2.5). Both medications were given for at least five days and until the use of a vitamin K antagonist resulted in an INR &gt;2.0. All patients were then treated with a vitamin K antagonist for three months (target INR: 2.0 to 3.0). Results included the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of confirmed recurrent venous thromboembolism was similar in the two treatment arms, being 3.8 and 5.0 percent in the",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      and unfractionated",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      groups, respectively.",
"     </li>",
"     <li>",
"      The incidences of major bleeding (2.0 versus 2.4 percent), clinically relevant nonmajor bleeding (5.7 versus 8.4 percent), thrombocytopenia (0.9 versus 1.2 percent), and death (5.2 versus 4.4 percent) were similar in the",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      treatment arms, respectively. Lower rates of major bleeding (approximately 1 percent) were reported during the five to seven days of fondaparinux or heparin treatment.",
"     </li>",
"     <li>",
"      Early hospital discharge occurred in 14.5 percent of patients randomly assigned to treatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      , without adverse effect on the rate of recurrence of VTE or major bleeding.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Deep vein thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The double-blind MATISSE trial randomly assigned 2205 patients with acute symptomatic deep vein thrombosis (DVT) to initial treatment with either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    (5, 7.5, or 10 mg SQ once daily for those weighing &lt;50, 50 to 100, or &gt;100 kg, respectively) or the low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    &nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    SQ twice daily) for a period of at least five days and until vitamin K antagonists induced an international normalized ratio (INR) &gt;2.0 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/32\">",
"     32",
"    </a>",
"    ]. Vitamin K antagonists were started within 72 hours of treatment with fondaparinux or enoxaparin, and were continued (target INR 2.0 to 3.0) for three months.",
"   </p>",
"   <p>",
"    The primary efficacy outcome, the three-month incidence of symptomatic recurrent VTE, was 3.9 and 4.1 percent for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    , respectively. The incidences of major bleeding during the initial treatment period (1.1 and 1.2 percent, respectively) and overall mortality rates (3.8 and 3.0 percent, respectively) were also similar. Thrombocytopenia occurred in seven patients (0.6 percent) in each group, and was not associated with either thromboembolism or antiplatelet antibodies. It was concluded that once daily fondaparinux was at least as effective and safe as twice-daily body weight adjusted dose enoxaparin for the initial treatment of patients with symptomatic DVT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OTHER POTENTIAL USES",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    has also been studied for the prevention of thrombotic events in a number of other clinical settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Acutely ill medical patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ARTEMIS randomized, double-blind placebo-controlled study was designed to evaluate the safety and efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    in preventing VTE in 849 patients &ge;60 years of age hospitalized due to acute cardiac, respiratory, infectious, or inflammatory disease, expected to remain in bed for at least 4 days, and considered to be at moderate risk for VTE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/33\">",
"     33",
"    </a>",
"    ]. Treatment with fondaparinux (2.5 mg SQ once daily, starting within 48 hours of hospital admission and continuing for a total of 6 to 14 days) significantly reduced the risk of VTE from 10.5 percent in the placebo arm to 5.6 percent (relative risk reduction 47 percent, 95% CI 8-69). Symptomatic VTE occurred in five patients in the placebo group and none in the fondaparinux group. Major bleeding occurred in one patient (0.2 percent) in each group.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Coronary heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    has been evaluated in a number of different coronary heart disease settings, including unstable angina, acute myocardial infarction, as well as in patients undergoing percutaneous coronary interventions. These are described elsewhere in UpToDate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/37/41562?source=see_link&amp;anchor=H26#H26\">",
"     \"Antithrombotic therapy for intracoronary stent implantation: Clinical trials\", section on 'Fondaparinux'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/2/5162?source=see_link&amp;anchor=H39#H39\">",
"     \"Anticoagulant therapy in non-ST elevation acute coronary syndromes\", section on 'Fondaparinux'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/57/5018?source=see_link&amp;anchor=H21650089#H21650089\">",
"     \"Anticoagulant therapy in acute ST elevation myocardial infarction\", section on 'Fondaparinux'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Heparin induced thrombocytopenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    does not interact with platelets or platelet factor 4, and thus, unlike",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , is not expected to induce thrombocytopenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40890?source=see_link&amp;anchor=H3#H3\">",
"     \"Heparin-induced thrombocytopenia\", section on 'Pathophysiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In other studies,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    did not interact in vitro with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    -dependent antibodies from patients with heparin-induced thrombocytopenia (HIT) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/34-36\">",
"     34-36",
"    </a>",
"    ], and HIT IgG antibodies did not recognize platelet factor 4 mixed with fondaparinux [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/20\">",
"     20",
"    </a>",
"    ]. Finally, no patient receiving fondaparinux in the major orthopedic prevention trials developed clinical HIT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/20\">",
"     20",
"    </a>",
"    ]. However, in other case reports, clinical HIT was seen after the use of this agent, along with a strongly positive platelet serotonin-release assay in the absence of added drug as well as in the presence of added drug [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/37-40\">",
"     37-40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40890?source=see_link&amp;anchor=H9#H9\">",
"     \"Heparin-induced thrombocytopenia\", section on 'Delayed onset HIT'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although not formally approved for this indication, there are several reports of patients with HIT being successfully managed with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    in lieu of a direct thrombin inhibitor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/41-47\">",
"     41-47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40890?source=see_link&amp;anchor=H39#H39\">",
"     \"Heparin-induced thrombocytopenia\", section on 'Fondaparinux'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Delayed use of fondaparinux in orthopedic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The FLEXTRA trial was designed to compare the benefit-to-risk ratio of altering the timing of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    administration following major orthopedic surgery of the lower extremities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/48\">",
"     48",
"    </a>",
"    ]. Over 2000 patients were randomly assigned to treatment with fondaparinux using the standard (first dose six to eight hours post-surgery) or an alternate timing regimen (first dose at 7 to 9 AM on the morning after surgery), and continued for 7 to 10 days. The incidences of symptomatic VTE (1.9 versus 1.8 percent) and major bleeding (1.2 versus 0.7 percent) at six weeks were similar between the standard and alternative timing regimens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Surgical prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    has been approved by the FDA for the prophylaxis of deep vein thrombosis in patients undergoing surgery for hip fracture, hip replacement, or knee replacement, for extended DVT prophylaxis following hip fracture surgery, and for patients at risk for thromboembolic complications following abdominal surgery. The approved dose for prevention of postoperative VTE is 2.5 mg SQ once daily, to be initiated six to eight hours following completion of surgery (ie, skin closure).",
"   </p>",
"   <p>",
"    Additional information concerning selection of the appropriate agent for prophylaxis in this setting, including a discussion of ease of administration, requirements for monitoring, cost, and effectiveness can be found elsewhere in the program. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link&amp;anchor=H9#H9\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\", section on 'Prevention of VTE'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link&amp;anchor=H30#H30\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16320576\">",
"    <span class=\"h3\">",
"     Stopping fondaparinux prior to elective surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticoagulant activity persists for about three to five half-lives following discontinuation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    , or a period of two to four days in patients with normal renal function. A longer period would be required in those with reduced renal function. No antidote is available to reduce this waiting period. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Pharmacology'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Pulmonary embolism and deep vein thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    has been approved by the FDA for the treatment of acute symptomatic pulmonary embolism (PE) as well as for the treatment of acute symptomatic deep vein thrombosis (DVT) when used in conjunction with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    . The recommended dose for DVT or PE is 5, 7.5, or 10 mg SQ once daily for patients weighing &lt;50, 50 to 100, or &gt;100 kg, respectively. Oral warfarin therapy should be started as soon as possible following initiation of treatment with fondaparinux. Treatment with fondaparinux should be continued for at least five days and until the INR is in the therapeutic range (ie, 2.0 to 3.0).",
"   </p>",
"   <p>",
"    Additional information concerning selection of the appropriate agent for the initial treatment of DVT or PE can be found elsewhere in the program. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link\">",
"     \"Treatment of lower extremity deep vein thrombosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42503?source=see_link\">",
"     \"Treatment of acute pulmonary embolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Regional anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to the manufacturer, no spinal or epidural hematomas were reported when",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    was withheld until at least two hours after removal of epidural catheters. There was one epidural hematoma in the phase II study related to multiple attempts at placing an epidural catheter. Product labeling of this drug with respect to regional anesthesia is no different from that of low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     High risk patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been recommended that patients with the following characteristics",
"    <strong>",
"     NOT",
"    </strong>",
"    be treated with this agent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Underweight patients (ie, &lt;50 kg) when used in the",
"      <strong>",
"       prophylactic",
"      </strong>",
"      setting (ie, orthopedic surgery)",
"     </li>",
"     <li>",
"      Renal insufficiency (creatinine clearance &lt;30",
"      <span class=\"nowrap\">",
"       mL/min)",
"      </span>",
"     </li>",
"     <li>",
"      Hemorrhagic tendency",
"     </li>",
"     <li>",
"      Platelet count",
"      <span class=\"nowrap\">",
"       &lt;100,000/microL",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Use of this agent in the elderly (eg, &gt;75 years of age) appears to be safe, provided that the patient weighs &gt;50 kg and has normal renal function. In the therapeutic setting (ie, treatment of VTE), adults weighing &lt;50 kg should receive a lower dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    (5",
"    <span class=\"nowrap\">",
"     mg/day).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial in vivo studies in animals and in vitro studies in the perfused human placenta have failed to demonstrate placental transfer of this agent at currently recommended doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/6\">",
"     6",
"    </a>",
"    ]. However, small amounts of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    have been detected in the umbilical cord following multiple doses during pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/49\">",
"     49",
"    </a>",
"    ]. While there is only anecdotal experience attesting to the safety of fondaparinux during pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44408/abstract/49-54\">",
"     49-54",
"    </a>",
"    ], there has been considerable experience with low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    (LMWH). Both fondaparinux and LMWH carry class B labeling with respect to pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/46/18153?source=see_link\">",
"     \"Anticoagulation during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/1\">",
"      Danielsson A, Raub E, Lindahl U, Bj&ouml;rk I. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem 1986; 261:15467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/2\">",
"      Nijkeuter M, Huisman MV. Pentasaccharides in the prophylaxis and treatment of venous thromboembolism: a systematic review. Curr Opin Pulm Med 2004; 10:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/3\">",
"      Nagler M, Haslauer M, Wuillemin WA. Fondaparinux - data on efficacy and safety in special situations. Thromb Res 2012; 129:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/4\">",
"      Turpie AG, Gallus AS, Hoek JA, Pentasaccharide Investigators. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med 2001; 344:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/5\">",
"      Olson ST, Bj&ouml;rk I, Sheffer R, et al. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 1992; 267:12528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/6\">",
"      Lagrange F, Vergnes C, Brun JL, et al. Absence of placental transfer of pentasaccharide (Fondaparinux, Arixtra) in the dually perfused human cotyledon in vitro. Thromb Haemost 2002; 87:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/7\">",
"      Bauer KA. Fondaparinux sodium: a selective inhibitor of factor Xa. Am J Health Syst Pharm 2001; 58 Suppl 2:S14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/8\">",
"      Gallus AS, Coghlan DW. Heparin pentasaccharide. Curr Opin Hematol 2002; 9:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/9\">",
"      Lassen MR, Bauer KA, Eriksson BI, et al. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet 2002; 359:1715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/10\">",
"      Bijsterveld NR, Moons AH, Boekholdt SM, et al. Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation 2002; 106:2550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/11\">",
"      Bijsterveld NR, Vink R, van Aken BE, et al. Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers. Br J Haematol 2004; 124:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/12\">",
"      Paolucci F, Frasa H, Van Aarle F, et al. Two sensitive and rapid chromogenic assays of fondaparinux sodium (Arixtra) in human plasma and other biological matrices. Clin Lab 2003; 49:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/13\">",
"      PERSIST investigators. A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluation. J Thromb Haemost 2004; 2:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/14\">",
"      Bates SM, Weitz JI. The status of new anticoagulants. Br J Haematol 2006; 134:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/15\">",
"      van Gogh Investigators, Buller HR, Cohen AT, et al. Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med 2007; 357:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/16\">",
"      van Gogh Investigators, Buller HR, Cohen AT, et al. Extended prophylaxis of venous thromboembolism with idraparinux. N Engl J Med 2007; 357:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/17\">",
"      Amadeus Investigators, Bousser MG, Bouthier J, et al. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. Lancet 2008; 371:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/18\">",
"      Equinox Investigators. Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis. J Thromb Haemost 2011; 9:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/19\">",
"      B&uuml;ller HR, Gallus AS, Pillion G, et al. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. Lancet 2012; 379:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/20\">",
"      Warkentin TE, Cook RJ, Marder VJ, et al. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood 2005; 106:3791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/21\">",
"      Warkentin TE, Greinacher A, Koster A, et al. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:340S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/22\">",
"      Turpie AG, Bauer KA, Eriksson BI, et al. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet 2002; 359:1721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/23\">",
"      Bauer KA, Eriksson BI, Lassen MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001; 345:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/24\">",
"      Eriksson BI, Bauer KA, Lassen MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001; 345:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/25\">",
"      Agnelli G, Bergqvist D, Cohen AT, et al. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 2005; 92:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/26\">",
"      Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002; 162:1833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/27\">",
"      Turpie A, Bauer K, Eriksson B, et al. Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration. Thromb Haemost 2003; 90:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/28\">",
"      Eikelboom JW, Quinlan DJ, O'Donnell M. Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials. Circulation 2009; 120:2006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/29\">",
"      Eriksson BI, Lassen MR, PENTasaccharide in HIp-FRActure Surgery Plus Investigators. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 2003; 163:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/30\">",
"      Turpie AG, Bauer KA, Caprini JA, et al. Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: The randomized APOLLO study (abstract). Blood 2005; 106:85a.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/31\">",
"      B&uuml;ller HR, Davidson BL, Decousus H, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349:1695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/32\">",
"      B&uuml;ller HR, Davidson BL, Decousus H, et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 2004; 140:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/33\">",
"      Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006; 332:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/34\">",
"      Elalamy I, Lecrubier C, Potevin F, et al. Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia. Thromb Haemost 1995; 74:1384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/35\">",
"      Amiral J, Lormeau JC, Marfaing-Koka A, et al. Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 1997; 8:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/36\">",
"      Savi P, Chong BH, Greinacher A, et al. Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin. Blood 2005; 105:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/37\">",
"      Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 2007; 356:2653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/38\">",
"      Elalamy I, Tribout B. Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttal. J Thromb Haemost 2008; 6:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/39\">",
"      Warkentin TE, Lim W. Can heparin-induced thrombocytopenia be associated with fondaparinux use? Reply to a rebuttal. J Thromb Haemost 2008; 6:1243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/40\">",
"      Warkentin TE, Chakraborty AK, Sheppard JA, Griffin DK. The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome. Thromb Haemost 2012; 108:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/41\">",
"      Parody R, Oliver A, Souto JC, Fontcuberta J. Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 2003; 88:ECR32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/42\">",
"      Rubin N, Rubin J. Treatment of heparin induced thrombocytopenia with thrombosis (HITT) in pregnancy with fondaparinux (abstract). Blood 2003; 102:120b.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/43\">",
"      Lian EC, Chua L, Oberstein E, et al. Long-term use of fondaparinux in a patient with antiphospholipid syndrome, heparin-induced thrombocytopenia and refractoriness to coumadin (abstract). Blood 2003; 102:124b.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/44\">",
"      D'Amico EA, Villa&ccedil;a PR, Gualandro SF, et al. Successful use of Arixtra in a patient with paroxysmal nocturnal hemoglobinuria, Budd-Chiari syndrome and heparin-induced thrombocytopenia. J Thromb Haemost 2003; 1:2452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/45\">",
"      Harenberg J, J&ouml;rg I, Fenyvesi T. Treatment of heparin-induced thrombocytopenia with fondaparinux. Haematologica 2004; 89:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/46\">",
"      Kuo KH, Kovacs MJ. Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux. Thromb Haemost 2005; 93:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/47\">",
"      Warkentin TE, Pai M, Sheppard JI, et al. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. J Thromb Haemost 2011; 9:2389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/48\">",
"      Colwell CW Jr, Kwong LM, Turpie AG, Davidson BL. Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery. J Arthroplasty 2006; 21:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/49\">",
"      Dempfle CE. Minor transplacental passage of fondaparinux in vivo. N Engl J Med 2004; 350:1914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/50\">",
"      Hawkins D, Evans J. Minimising the risk of heparin-induced osteoporosis during pregnancy. Expert Opin Drug Saf 2005; 4:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/51\">",
"      Wijesiriwardana A, Lees DA, Lush C. Fondaparinux as anticoagulant in a pregnant woman with heparin allergy. Blood Coagul Fibrinolysis 2006; 17:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/52\">",
"      Harenberg J. Treatment of a woman with lupus and thromboembolism and cutaneous intolerance to heparins using fondaparinux during pregnancy. Thromb Res 2007; 119:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/53\">",
"      Mazzolai L, Hohlfeld P, Spertini F, et al. Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood 2006; 108:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44408/abstract/54\">",
"      Knol HM, Schultinge L, Erwich JJ, Meijer K. Fondaparinux as an alternative anticoagulant therapy during pregnancy. J Thromb Haemost 2010; 8:1876.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1319 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-B1A854215F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44408=[""].join("\n");
var outline_f43_23_44408=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Antidote",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Drug monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Renal clearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Dose range",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Longer-acting analogues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Platelet count monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PREVENTION OF POSTOPERATIVE VTE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Total hip replacement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hip fracture surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Knee surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Abdominal surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      INITIAL TREATMENT OF VENOUS THROMBOEMBOLISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OTHER POTENTIAL USES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Acutely ill medical patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Heparin induced thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Delayed use of fondaparinux in orthopedic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Surgical prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16320576\">",
"      - Stopping fondaparinux prior to elective surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Pulmonary embolism and deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Regional anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      High risk patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/1319\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1319|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/16/36110\" title=\"figure 1\">",
"      Mechanisms of action of heparin LMW heparin and fondaparinux",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/57/5018?source=related_link\">",
"      Anticoagulant therapy in acute ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/2/5162?source=related_link\">",
"      Anticoagulant therapy in non-ST elevation acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/59/37818?source=related_link\">",
"      Anticoagulants other than heparin and warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/46/18153?source=related_link\">",
"      Anticoagulation during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/37/41562?source=related_link\">",
"      Antithrombotic therapy for intracoronary stent implantation: Clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40890?source=related_link\">",
"      Heparin-induced thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33930?source=related_link\">",
"      Therapeutic use of heparin and low molecular weight heparin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42503?source=related_link\">",
"      Treatment of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=related_link\">",
"      Treatment of lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_23_44409="Stress urinary incontinence in women: Persistent/recurrent symptoms after surgical treatment";
var content_f43_23_44409=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Stress urinary incontinence in women: Persistent/recurrent symptoms after surgical treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/23/44409/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44409/contributors\">",
"     Daniel M Morgan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/23/44409/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44409/contributors\">",
"     Linda Brubaker, MD, FACS, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/23/44409/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/23/44409/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/23/44409/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent stress urinary incontinence (SUI) refers to symptoms of stress incontinence that persist despite performance of a surgical procedure intended to resolve these symptoms. Recurrent SUI refers to recurrence of such symptoms after a surgical treatment that had resulted in cure.",
"   </p>",
"   <p>",
"    The management of women with persistent or recurrent urinary stress incontinence after a surgical procedure should be individualized. The risks and benefits of any intervention should be considered in the context of the patient's previous medical and surgical history, co-morbidities, and expectations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a population-based study of over 40,000 United States women who underwent surgical treatment of stress incontinence, 8.6 percent underwent a second surgical treatment for stress incontinence within eight years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/1\">",
"     1",
"    </a>",
"    ]. Another estimate from a smaller prospective cohort of women who underwent surgical treatment of pelvic organ prolapse and urinary incontinence suggests that the rate of reoperation is as high as at least 17 percent over 10 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     REASONS FOR FAILURE OF INITIAL SURGICAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who fail a first operation may be fundamentally different than those who have good outcomes. Women with recurrent stress incontinence have urethral electromyography findings more consistent with poorer neuromuscular function than those who have not had a surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/3\">",
"     3",
"    </a>",
"    ]. Preoperative patient characteristics associated with a higher risk of failure of primary surgery for stress urinary incontinence (SUI) include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age over 70 to 75 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/4-6\">",
"       4-6",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Body mass index over 30",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/4,7\">",
"       4,7",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Diabetes mellitus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Preoperative mixed urinary incontinence [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/9,10\">",
"       9,10",
"      </a>",
"      ] and preoperative detrusor instability [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/11\">",
"       11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Preoperative urodynamic diagnosis of intrinsic sphincter deficiency (a urethral pressure profile of less than 20 cm water or a leak point pressure of less than 60 cm water) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/5,12-14\">",
"       5,12-14",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      History of concomitant pelvic organ prolapse [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The rate of",
"    <span class=\"nowrap\">",
"     recurrent/persistent",
"    </span>",
"    stress incontinence is also dependent upon the initial surgical procedure performed. Success rates can vary remarkably depending upon the population studied and the length of follow-up. Success rates of TVT as a primary surgery of women with urethral hypermobility and the absence of intrinsic sphincter deficiency can be as high as 97 percent. However, elderly women and those with intrinsic sphincter deficiency do not fare as well with success rates falling to 55 to 74 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/8\">",
"     8",
"    </a>",
"    ]. Failure of transobturator midurethral slings has been associated with urethral closure pressures of less than 40 cmH(2)O [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Comparison among surgical treatment for SUI is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/10/43177?source=see_link&amp;anchor=H14#H14\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\", section on 'Choosing a procedure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A major goal is to determine whether the patient's symptoms are due to",
"    <span class=\"nowrap\">",
"     persistent/recurrent",
"    </span>",
"    urinary stress incontinence or are related to another etiology. The evaluation of women with",
"    <span class=\"nowrap\">",
"     recurrent/persistent",
"    </span>",
"    urinary incontinence after surgical therapy is similar to that for primary incontinence. However, it is important to keep in mind that the vaginal and visceral anatomy may have been altered surgically. For instance, a suburethral sling procedure could precipitate new symptoms (ie, a sling may be obstructive leading to overactive bladder symptoms and overflow incontinence), fail to address symptoms (ie, an unrecognized diverticulum continues to create persistent post void dribbling or insensate urine loss), or increase the risk of complications with future treatment (ie, scarring in the retropubic space increasing the risk for bladder injury). A review of the urodynamic data obtained before the primary procedure may be helpful when discussing and considering how to proceed with future treatment.",
"   </p>",
"   <p>",
"    The evaluation of women with incontinence is discussed in detail separately; selected aspects of this evaluation are reviewed briefly below. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=see_link\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Type and severity of symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary incontinence is associated with a wide spectrum of symptom severity and impairment. Symptom severity can be described in terms of the number of leakage episodes per day, the number and type of pad utilized, as well as the condition of used pads (damp, wet, soaking). A voiding diary is useful in identifying symptoms related to fluid intake, bladder capacity, and type(s) of incontinence. The impact on quality of life can be assessed by how frequently symptoms prevent the patient from pursuing activities she normally enjoys, such as socializing, exercising, and traveling.",
"   </p>",
"   <p>",
"    The character and severity of the patient's symptoms should be compared to her status prior to surgical intervention. This information helps in making decisions about further management. As an example, it is important to determine whether the patient is having symptoms of urge incontinence (leakage of urine because of an inability to make it to the bathroom fast enough or because of a sudden urge to urinate) or those of stress incontinence (leakage of urine related to sudden increase in intraabdominal pressure), or a combination of both. De novo symptoms of urge incontinence are reported by 5 to 27 percent of patients after anti-incontinence procedures, and the treatment is different from that for urinary stress incontinence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/15\">",
"     15",
"    </a>",
"    ]. Other causes of incontinence and factors contributing to urine loss also need to be excluded. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=see_link\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link\">",
"     \"Treatment of urinary incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Medical history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient's overall medical status should be thoroughly assessed. Drugs prescribed for medical conditions can exacerbate incontinence symptoms due to their effects on lower urinary tract function. Commonly used medications that can have deleterious effects on lower urinary tract function include diuretics, estrogen, benzodiazepines, hypnotics, and laxatives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/15\">",
"     15",
"    </a>",
"    ]. Aging, obesity, and comorbid diseases (eg, hypertension, Parkinsonism, cognitive impairment, back problems, diabetes mellitus, and chronic pulmonary disease) are also risk factors for urinary incontinence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\", section on 'Types of urinary incontinence'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Surgical history",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to determine the type of anti-incontinence surgery previously performed and the temporal relationship of symptoms with respect to the procedure(s). Women who undergo prolapse and incontinence surgery concomitantly are significantly less likely to need a repeat operation for stress incontinence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Rates of recurrent stress incontinence will also vary according to the procedure. As an example, recurrent stress incontinence is common and to be expected after intraurethral bulking therapy with a biodegradable agent, such as collagen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/18\">",
"     18",
"    </a>",
"    ], but generally not common and not expected after a midurethral polypropylene sling. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/10/43177?source=see_link\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H2819228#H2819228\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Outcome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/39/33401?source=see_link&amp;anchor=H941767#H941767\">",
"     \"Stress urinary incontinence in women: Transobturator midurethral slings\", section on 'Outcome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pelvic examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pelvic examination may reveal anatomic changes that could account for the patient's symptoms. Prior surgery for urinary incontinence can result in iatrogenic prolapse (eg, enterocele after retropubic urethropexy), hypersuspension of the urethra, focal areas of discomfort, or changes in vaginal anatomy. Placement of synthetic materials or permanent sutures during previous prolapse or incontinence surgeries can lead to erosions, chronic vaginal discharge, or vaginitis. Urethral abnormalities, such as diverticula or Skene's duct cysts, and hypoestrogenic vaginal epithelium can develop and may alter urethral function. Previous repairs or excisions of these abnormalities can lead to fistulae or post-void dribbling, which may mimic stress incontinence. In addition, any combination of these complications may exacerbate a patient's perception of recurrent symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diagnostic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;We perform the following tests in women with",
"    <span class=\"nowrap\">",
"     persistent/recurrent",
"    </span>",
"    stress incontinence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Urinalysis &mdash; The urinalysis screens for infection, hematuria, and glucosuria. These findings may be a marker for a lower urinary tract condition with a deleterious effect on lower urinary tract function. Erosion of synthetic material into the bladder, formation of a bladder stone around a foreign body, cystitis, or malignancy may present as urinary incontinence. Cystoscopy is indicated if any of these lower urinary tract conditions are suspected.",
"     </li>",
"     <li>",
"      Post void residual &mdash; Measurement of post void residual urine assesses bladder emptying and can differentiate symptoms due to overflow incontinence from those due to recurrent stress incontinence. If bladder emptying is not adequate, the patient with recurrent urinary incontinence symptoms is unlikely to benefit from additional intervention for stress incontinence.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A urodynamic evaluation can be helpful, especially if pelvic examination, urinalysis, and post void residual are normal. A cystometrogram in which the bladder is filled retrograde with 300 to 500 mLs assesses bladder compliance (change in pressure with change in volume). It can elicit evidence of detrusor instability and will provide an estimate of bladder capacity. We tend to ask patients to perform a stress test (cough or valsalva to determine if stress incontinence is present) when the bladder is filled with approximately 300 mL, a volume when most patients have the sensation of reasonably comfortable bladder fullness. If multichannel urodynamics are being performed, urethral sphincter competence is assessed with a urethral pressure profile and cough and valsalva-leak point pressures. These procedures are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32120?source=see_link\">",
"     \"Urodynamic evaluation of women with incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We have found that fluoroscopic evaluation may be useful if multiple surgeries have been attempted, as this test will sometimes provide information on urethral mobility and bladder morphology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of persistent or recurrent stress incontinence is primarily symptoms based. A patient description of troublesome stress incontinence should be the indication for additional evaluation and intervention. Bothersome incontinence which adversely affects an individual's lifestyle deserves attention. The invasiveness of intervention is a function of symptom severity, the type of symptoms, and medical factors.",
"   </p>",
"   <p>",
"    The threshold for intervention is not an affirmative answer to the question, \"Do you ever experience stress incontinence when coughing, sneezing, etc?\" The patient may well answer \"yes,\" but if that symptom is only experienced during an exacerbation of asthma or when an unexpected sneeze strikes with a full bladder, it would be unrealistic to think that additional intervention is going to provide a significant benefit.",
"   </p>",
"   <p>",
"    Another scenario might be the patient who describes frequent and bothersome urinary incontinence, but relatively rare and innocuous stress incontinence. Evaluation and treatment should probably be directed towards urgency associated symptoms (eg, behavioral modification, use of anti-cholinergics).",
"   </p>",
"   <p>",
"    In summary, a thoughtful conversation between patient and physician that reveals stress incontinence as the primary symptom of concern is the best barometer of the need for further evaluation.",
"   </p>",
"   <p>",
"    The choice of treatment depends upon several factors, including comorbid medical conditions, findings of pelvic organ support and urodynamics, and patient expectations and tolerance of potential adverse effects of intervention. A patient who underwent a surgical procedure with a high failure rate (see above), who has no significant medical contraindications to surgery, and who has urethral hypermobility may be a good candidate for another surgical procedure, such as a midurethral or pubovaginal sling procedure. In contrast, a patient with multiple comorbid conditions, a large vaginal vault prolapse, and no tolerance for the possibility of urinary retention in the short- or long-term is a poor surgical candidate probably better treated with nonoperative (eg, pessary)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    minimally invasive (eg, collagen) options [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/4\">",
"     4",
"    </a>",
"    ]. Many patients will occupy the territory between these extremes. They will have a few comorbid conditions, some pelvic floor relaxation, and some degree of frustration about the recurrence or persistence of stress incontinence. A careful",
"    <span class=\"nowrap\">",
"     risk/benefit",
"    </span>",
"    analysis by patient and physician will improve the likelihood of realistic patient expectations and successful intervention.",
"   </p>",
"   <p>",
"    The section below provides a description of nonsurgical and surgical options. These interventions are not necessarily employed in this order. The benefit of the nonsurgical options is that they carry little risk of morbidity and do not preclude the use of more definitive, but invasive, options in the future.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Nonsurgical options",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on the usefulness of medical intervention for treatment of stress urinary incontinence (SUI) among women with",
"    <span class=\"nowrap\">",
"     persistent/recurrent",
"    </span>",
"    SUI after surgical therapy is generally lacking. The following discussion is largely based upon data from studies in the overall population of women with SUI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Pessaries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pessaries benefit many women with SUI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. An increase in maximum urethral closure pressure and functional urethral length may explain how pessaries promote stress continence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A ring or incontinence dish pessary is used for stress incontinence. Successful fitting has been reported in 71 to 89 percent of individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/19,21,23\">",
"     19,21,23",
"    </a>",
"    ]. Individuals who have not had a hysterectomy or prolapse surgery are more likely to be successfully fitted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/23\">",
"     23",
"    </a>",
"    ]. Those women with a posterior prolapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/23\">",
"     23",
"    </a>",
"    ], a vaginal length less than or equal to 6 cm or a genital hiatus greater than 4 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/24\">",
"     24",
"    </a>",
"    ] are less likely to be successfully fitted. The number of women successfully fitted with a pessary who continue to use it for at least six months ranges from 55 to 89 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/19,23,24\">",
"     19,23,24",
"    </a>",
"    ]. It is not clear which patients are most likely to continue use. One study found that older and sexually inactive women were more likely to continue use, but another study reported that sexually active women were more likely to continue pessary use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/7/17530?source=see_link\">",
"     \"Vaginal pessary treatment of prolapse and incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Medication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical therapy can improve symptoms of SUI, but the proportion of patients reporting cure or improvement is less than with surgical treatment. Options include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/62/37864?source=see_link\">",
"       Duloxetine",
"      </a>",
"      is a selective norepinephrine and serotonin reuptake inhibitor. There are, however, several medical conditions where its use is contraindicated (eg, chronic liver disease, concomitant use of MAO inhibitors). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link&amp;anchor=H22#H22\">",
"       \"Treatment of urinary incontinence\", section on 'Duloxetine'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/41/41624?source=see_link\">",
"       Imipramine",
"      </a>",
"      is a tricyclic antidepressant, which has alpha-agonist and anticholinergics effects. It can be used in women with mixed incontinence; however, stress leakage could be worsened if the postvoid residual increases, and efficacy data are lacking. Patients with higher pretreatment maximum urethral closure pressures are more likely to have a successful response to treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/25\">",
"       25",
"      </a>",
"      ]. Imipramine is not advised for older patients as anticholinergic side effects and orthostatic hypotension may be significant. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link&amp;anchor=H21#H21\">",
"       \"Treatment of urinary incontinence\", section on 'Imipramine'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In randomized trials, neither electrical stimulation therapy nor oral estrogen therapy significantly improved symptoms of stress incontinence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link&amp;anchor=H30#H30\">",
"     \"Treatment of urinary incontinence\", section on 'Electrical'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link&amp;anchor=H23#H23\">",
"     \"Treatment of urinary incontinence\", section on 'Estrogen'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Surgical options",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few case series to guide surgeons in the selection of secondary continence procedures. The choice of surgical procedure will depend upon the patient's medical and surgical history and the findings of the diagnostic workup. A definitive approach is desired by many patients, but those at high risk for perioperative morbidity may be better served by less invasive options (ie, intra-urethral injections), even if repeat treatments are needed.",
"   </p>",
"   <p>",
"    Retropubic urethropexy, pubovaginal sling, and midurethral sling procedures have all been used for persistent SUI symptoms. It appears that a pubovaginal sling is more effective for persistent or recurrent stress incontinence than retropubic urethropexy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/28\">",
"     28",
"    </a>",
"    ]; however, the likelihood of symptom relief decreases with each subsequent surgery. The approach chosen is dependent upon the patient's history and diagnostic work-up and is directed towards the presumed reason for failure. If the urethra is well-supported, the urethral closure pressure is less than 10 cm water, or there is other",
"    <span class=\"nowrap\">",
"     imaging/diagnostic",
"    </span>",
"    evidence of intrinsic sphincter deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/5\">",
"     5",
"    </a>",
"    ], a pubovaginal sling may better promote continence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/28\">",
"     28",
"    </a>",
"    ]. A midurethral sling procedure with polypropylene may also be an effective choice after surgical failure (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Periurethral injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethral injection therapy acts by focal expansion of periurethral tissues, thereby augmenting pressure transmission to the proximal or midurethra. It is the least invasive surgical option for treatment of recurrent stress incontinence symptoms. The injection is administered as an outpatient procedure, under local anesthesia.",
"   </p>",
"   <p>",
"    Women with comorbidities that may greatly increase perioperative morbidity, who have already undergone multiple operations, or who strongly desire to avoid surgical intervention are the most appropriate candidates for injection therapy. The optimal route and site of urethral injection have not been determined. Endoscopic, transurethral injection at the vesical neck and transvaginal periurethral injection are commonly used techniques. &nbsp;Trials evaluating variations in injection techniques, transurethral and periurethral [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/29\">",
"     29",
"    </a>",
"    ] needle passage, and site of injection, bladder neck versus the mid-urethra, have not reported significant differences with respect to continence rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/30\">",
"     30",
"    </a>",
"    ]. Periurethral injections may be associated with higher, complication rates especially urinary retention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There have been several significant developments regarding materials available for injection therapy. In 2011, Bard&reg; discontinued production of glutaraldehyde crosslinked bovine collagen (Contigen&trade;). This formulation of collagen was well tolerated and became a standard against which all other injectable were compared since its introduction in 1993. Its most significant shortcoming was the need for repeat injections due to its biodegradability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/18,31\">",
"     18,31",
"    </a>",
"    ]. For patients experiencing recurrent stress incontinence after surgery, Contigen&trade; could be highly effective, providing cure or significant improvement in up to 93 percent. As is well known, however, its effectiveness eventually wanes and, in this same study, 24 percent eventually proceed with a pubovaginal sling with autologous fascia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/32\">",
"     32",
"    </a>",
"    ]. With Contigen&trade; no longer available, it is not clear what the next best alternative is with respect to tolerability and durability. The products discussed at greater length below are those that compared favorably to Contigen&trade; and that have been widely used. &nbsp;",
"   </p>",
"   <p>",
"    Non-animal stabilized hyaluronic acid dextranomer gel",
"    <span class=\"nowrap\">",
"     (NASHA/Dx)",
"    </span>",
"    is a biodegradable product used in Europe for several years, but not approved in the United States. The outcomes of treatment of na&iuml;ve patients were promising with 77 percent of patients responding to therapy at 12 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/33\">",
"     33",
"    </a>",
"    ]. However, a subsequent randomized controlled clinical trial in the United States eventually found it to be less effective than Contigen&reg; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/34\">",
"     34",
"    </a>",
"    ]. As expected with a biodegradable agent, subsequent studies demonstrated the need for repeat injections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/35\">",
"     35",
"    </a>",
"    ]. More troubling, however, are several case series reporting",
"    <span class=\"nowrap\">",
"     granuloma/abscess",
"    </span>",
"    formation in up to 14 to 28 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/36\">",
"     36",
"    </a>",
"    ]. Its use for recurrent stress incontinence has not been reported.",
"   </p>",
"   <p>",
"    Durasphere EXP (Coloplast [US], Minneapolis, MN, US) consists of carbon-coated zirconium oxide beads suspended in a water-based gel. It was approved for use in 1999 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/37\">",
"     37",
"    </a>",
"    ]. In a multicenter, randomized controlled trial, there was a higher (although not significantly so) rate of success at 12 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/37\">",
"     37",
"    </a>",
"    ] for women treated with Durasphere compared to Contigen&trade;. As a permanent material, it was hoped that repeat injections would be needed. Unfortunately, its effectiveness declined with time in a fashion similar to that observed with Contigen&trade;. At 12, 24, and 36 months, it remained effective in only 35, 33 and 21 percent of patients, rates not different from the 33, 19 and 9 percent observed with Contigen&trade; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/38\">",
"     38",
"    </a>",
"    ]. Prior hysterectomy was identified as a risk factor for failure with Durasphere, but prior incontinence surgery was not.",
"   </p>",
"   <p>",
"    Macroplastique (Uroplasty Inc, Minnetonka, Minnesota, US) is crosslinked polydimethylsiloxane. Approved for use in 2006, it has shown promise with follow-up of 24 months. In one case series, mean pad weight decreased from 29 to 4 grams [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/39\">",
"     39",
"    </a>",
"    ] and 84 percent of patients reported that they remained either significantly improved or cured. A second case series with follow-up ranging from 12 to 62 months was also notable for significant decreases in symptom severity and increases in quality of life scores. In these studies, patients with recurrent stress incontinence made up slightly less than one third of the cohorts and previous surgery was not identified as a risk factor for failure.",
"   </p>",
"   <p>",
"    Coaptite&trade; (Boston Scientific, Natick, Massachusetts, USA) is made of calcium hydroxylapatite suspended in a water and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/32/14852?source=see_link\">",
"     glycerin",
"    </a>",
"    gel and was approved for use in 2005. Coaptite&trade; provided at least a 50 percent drop in 24-hour pad weights for 62 percent of patients. This study involved a group of patients who had persistent urinary incontinence after surgery, but their results were not analyzed separately. During this same study, two serious adverse events were noted. One involved migration of the injected material towards the meatus and the other involved migration superior to the bladder neck obscuring a ureteral orifice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/40\">",
"     40",
"    </a>",
"    ]. Since this study, two additional case reports of urethral prolapse involving the injected material migrating towards the meatus have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Durasphere, Macroplastique and Coaptite have all been found to be &ldquo;not inferior&rdquo; to Contigen while",
"    <span class=\"nowrap\">",
"     NASHA/Dx,",
"    </span>",
"    the only other biodegradable product, has been found to be less effective than Contigen&trade;. &nbsp;The products have not been compared to each other in trials as they were to Contigen&trade;. They are hypoallergenic (unlike Contigen&trade;), but all injectables carry the potential for erosion, migration, and rare but unanticipated complications such as urethral prolapse. There is also the potential for more significant morbidity with the use of carbon coated zirconium beads which may migrate or form granulomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/43\">",
"     43",
"    </a>",
"    ] and silicone which has been associated with development of autoimmune disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/44\">",
"     44",
"    </a>",
"    ]. Autologous fat, polytetrafluoroethylene (Teflon), and ethylene vinyl alcohol (Tegress) are not recommended due to adverse health consequences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Retropubic urethropexy (Burch colposuspension)",
"    </span>",
"    &nbsp;&mdash;&nbsp;One case series reports that the efficacy of retropubic urethropexy decreased from 81 percent to 25 percent to 0 percent for women with one, two and three previous surgeries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Bladder neck sling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder neck slings are suburethral slings placed at the level of the proximal urethra or bladder neck. These are also referred to as pubovaginal slings when the arms of the sling material are affixed to the anterior rectus fascia rather than the pubic bone or Cooper&rsquo;s ligament. Use of bladder neck slings has largely been replaced by midurethral sling procedures. Current use is mainly for women with recurrent SUI following surgical treatment.",
"   </p>",
"   <p>",
"    The median SUI cure rate for bladder neck slings with at least 48-month follow up is 82 percent (95% CI 67-93) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/48\">",
"     48",
"    </a>",
"    ]. In a classic 1978 study, 80 percent of the patients had had surgery for incontinence, and a pubovaginal sling with autologous fascia cured 81 percent. In contrast, the success rate reported during a recent randomized controlled clinical trial was 47 percent. The difference in success rates is likely related to methodology and the use of a strict composite of subjective and objective criteria such as no self reported symptoms, minimal increase in 24-hour pad weight, negative full bladder stress test and no retreatment of any kind. Only 15 percent of the women from the more recently performed study had previous incontinence surgery and their success rate was not reported to be different [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bladder neck slings are typically made of autologous fascia. Autografts appear to perform better than cadaveric tissue (allografts) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/50-54\">",
"     50-54",
"    </a>",
"    ]. The durability of cadaveric tissue has been questioned, leading to a marked decrease in their use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/48\">",
"     48",
"    </a>",
"    ]. The most troubling data regarding allografts are the evidence of tissue failure. In 12 cases requiring reoperation after use of cadaveric fascia, the graft material could be found in only 7 cases and most grafts revealed areas of degeneration and evidence of immune reaction.",
"   </p>",
"   <p>",
"    The data on use of xenografts for bladder neck slings are limited, but suggest that this material is less optimal than autografts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/55-58\">",
"     55-58",
"    </a>",
"    ]. Study of these materials in the setting of recurrent stress incontinence has not been done.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Midurethral sling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Synthetic midurethral slings are an effective option to treat persistent or recurrent SUI. The median cure rate for synthetic mid-urethral slings is 84 percent (95% CI 77-89) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/48\">",
"     48",
"    </a>",
"    ]. Among women who had a history of a previous, unspecified incontinence procedure, the effectiveness of a midurethral sling for recurrent stress incontinence did not differ from those having a primary procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. In cases where patients have had a previous midurethral sling, some case series have suggested cure rates similar to a primary procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/61,62\">",
"     61,62",
"    </a>",
"    ], while others reported lower cure rates, ranging from 55 to 74 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Repeat midurethral sling placement for recurrent stress incontinence may be more effective with a retropubic approach than with a transobturator approach. The subjective cure rate among 77 women with recurrent incontinence treated over an eight-year period was 71 percent for those undergoing a retropubic sling and 48 percent for those undergoing a transobturator approach.",
"   </p>",
"   <p>",
"    There are several novel approaches to management of recurrent SUI in women who have undergone previous midurethral sling surgery. Successful resolution of SUI after adjustment of an existing midurethral sling has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/65\">",
"     65",
"    </a>",
"    ]. Adjustable midurethral slings (eg, Remeex, Ajust&trade;) are single incision slings which allow postoperative adjustment of sling tension and are a new development. As an example, in one study, SUI was cured in 21 of 25 women with recurrent SUI after previous anti-incontinence surgery who underwent placement of the AMI&reg; adjustable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/66\">",
"     66",
"    </a>",
"    ]. Another novel approach is the use of spiral slings; these are transvaginal slings that encircle the urethra and are held in place by sutures that pass through the retropubic space [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/67\">",
"     67",
"    </a>",
"    ]. The target population for spiral slings are women with neurologic disease or a fixed, open, nonfunctioning urethra (referred to as a &ldquo;lead pipe&rdquo; or &ldquo;pipe stem&rdquo; urethra [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/68\">",
"     68",
"    </a>",
"    ]). In a prospective study, 20 of 28 women had successful treatment of persistent SUI after spiral sling placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/69\">",
"     69",
"    </a>",
"    ]. Further study is needed of these techniques. These procedures are likely to be highly dependent upon a combination of surgical and device-specific technical expertise.",
"   </p>",
"   <p>",
"    The use of a single incision midurethral sling in the setting of recurrent stress incontinence has not been studied, but seems ill advised with currently available techniques. Several studies have reported significantly lower cure rates when such a sling is used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/70,71\">",
"     70,71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Artificial urinary sphincter",
"    </span>",
"    &nbsp;&mdash;&nbsp;The artificial urinary sphincter (American Medical Systems 800) is rarely used in women because complications from the device are common. However, women with severe incontinence who are refractory to other treatments may benefit from artificial sphincter devices, which can be placed abdominally or transvaginally. The following types and frequencies of complications have been reported: mechanical failure (3 to 33 percent), early",
"    <span class=\"nowrap\">",
"     infection/erosion",
"    </span>",
"    (4.5 to 67 percent), late erosion (15 percent), and delayed recurrent incontinence (7 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/72\">",
"     72",
"    </a>",
"    ]. Placement of an artificial sphincter does not preclude sexual activity or pregnancy.",
"   </p>",
"   <p>",
"    In 68 female patients who underwent sphincter placement, only 37 percent continued to use it seven years later, largely because of the significant complications associated with it [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/73\">",
"     73",
"    </a>",
"    ]. Infection or erosion accounted for removal in almost one-half of the women who discontinued use. Mechanical failure with the need for reoperation was common, even among those who continued to use the device.",
"   </p>",
"   <p>",
"    Due to this extremely high complication rate and need for subsequent intervention, we feel use of the device should be restricted to patients who have severe, recurrent incontinence, and understand the complications associated with it and the likelihood they will need another operation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Urinary diversion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary diversion is the most invasive intervention for treatment of recurrent stress incontinence, and is rarely performed for this indication. Urinary diversions can be incontinent or continent. Options for an incontinent diversion or conduit diversion include suprapubic catheter drainage, an ileovesicostomy where ileum is anastomosed to the bladder and drains via a stoma, and colonic conduit drainage, which requires ureteral reimplantation. Continent diversions became possible with development of clean intermittent catheterization techniques and development of surgical procedures in which a detubularized segment of bowel is used as catheterizable stoma. Many series have reported continence rates greater than 90 percent with strict adherence to a catheterization protocol.",
"   </p>",
"   <p>",
"    However, each of these approaches has been associated with a significant risk of complications, including stomal stenosis, ureteral damage (with reimplantation procedures), nutritional deficiencies (when ileum is for the conduit), and the potential for metabolic changes (hyperchloremic acidosis when colon is used as the conduit) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of surgery for recurrent stress incontinence requires consideration of the previous surgery performed, the patient's history, and their physical and diagnostic findings. If the patient had one previous surgery, a retropubic urethropexy, pubovaginal sling or midurethral sling may be satisfactory options. When multiple procedures have already been performed, there is evidence that a pubovaginal sling is likely the better option than retropubic urethropexy. The success rates of pubovaginal sling with one, two, and three surgeries were 77, 73, and 38 percent versus 81, 25, and 0 percent for retropubic urethropexy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/23/44409/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since there is little evidence regarding the efficacy of interventions, decisions regarding surgical treatment of recurrent or persistent stress incontinence are best made on a case by case basis. It is important to note that midurethral sling procedures such as TVT may perform as well as pubovaginal sling. When advising patients who have stress incontinence and can tolerate surgery and anesthesia, we make a decision between pubovaginal sling and TVT by considering the perioperative risks associated with length of surgery (pubovaginal sling takes longer), length of post-operative recovery (harvesting fascia leads to great post-operative pain and longer recovery), the risk of erosion (polypropylene is synthetic and carries a higher risk than autologous fascia), and the risk of urinary retention and voiding dysfunction (which can occur with either procedure).",
"   </p>",
"   <p>",
"    When considering success or failure rates for any of the procedures described above, it is important to remember that the definition of success is not uniform. Many authors did not report symptoms of urge incontinence as a failure if symptoms of stress incontinence were cured. This lack of uniformity in outcomes creates a lack of transparency complicating study comparison.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/19/19764?source=see_link\">",
"       \"Patient information: Urinary incontinence treatments for women (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preoperative patient characteristics associated with a higher risk of failure of primary surgery for stress urinary incontinence (SUI) include advanced age, obesity, presence of mixed urinary incontinence, and urodynamic diagnosis of intrinsic sphincter deficiency. The rate of",
"      <span class=\"nowrap\">",
"       recurrent/persistent",
"      </span>",
"      stress incontinence also depends upon the initial surgical procedure performed. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Reasons for failure of initial surgical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A major goal of clinical evaluation is to determine whether the patient's symptoms are due to",
"      <span class=\"nowrap\">",
"       persistent/recurrent",
"      </span>",
"      urinary stress incontinence or related to another etiology. Clinical evaluation should include assessment of the type and severity of symptoms, a thorough medical history looking for factors that may be contributing to urine leakage, identification of the type of anti-incontinence surgery since cure rates vary, and pelvic examination to look for anatomic changes that could account for her symptoms. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A urinalysis and post void residual are necessary. If pelvic examination, urinalysis, and post void residual are normal, a urodynamic evaluation may identify abnormalities (eg, intrinsic sphincter deficiency, detrusor overactivity, abnormal bladder compliance) that could be contributing to the patient's symptoms. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnostic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management decisions involve consideration of multiple factors, including the results of the clinical and diagnostic evaluation, patient tolerance of short- and long-term side effects and complications, tissue status in the area of potential repeat surgery, and expectations of additional intervention. Careful evaluation of these factors, the risks and benefits, and possible complications will help form an appropriate treatment plan. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A stepped approach to management is a reasonable approach:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For women who are willing and able to use a pessary, we suggest a trial of a continence pessary (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In contrast to medications and surgical procedures, these devices are generally free of side effects and complications if cared for properly. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Pessaries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For surgical treatment of recurrent stress incontinence among patients who have high perioperative risks, we suggest the use of intra-urethral injections.",
"     </li>",
"     <li>",
"      For surgical treatment of recurrent or persistent stress incontinence among women who can tolerate surgery, we suggest the pubovaginal sling with autologous fascia or a midurethral sling procedure (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Compared to other procedures (urethral injection, artificial sphincter, urinary diversion), these procedures have the most favorable combination of success, durability, side effects, and complications. The choice of procedure needs to be considered on a case by case basis. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Surgical options'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/1\">",
"      Fialkow M, Symons RG, Flum D. Reoperation for urinary incontinence. Am J Obstet Gynecol 2008; 199:546.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/2\">",
"      Denman MA, Gregory WT, Boyles SH, et al. Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 2008; 198:555.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/3\">",
"      Kenton K, Mahajan S, Fitzgerald MP, Brubaker L. Recurrent stress incontinence is associated with decreased neuromuscular function in the striated urethral sphincter. Am J Obstet Gynecol 2006; 194:1434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/4\">",
"      Hellberg D, Holmgren C, Lanner L, Nilsson S. The very obese woman and the very old woman: tension-free vaginal tape for the treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/5\">",
"      Rezapour M, Falconer C, Ulmsten U. Tension-Free vaginal tape (TVT) in stress incontinent women with intrinsic sphincter deficiency (ISD)--a long-term follow-up. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12 Suppl 2:S12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/6\">",
"      Richter HE, Goode PS, Brubaker L, et al. Two-year outcomes after surgery for stress urinary incontinence in older compared with younger women. Obstet Gynecol 2008; 112:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/7\">",
"      Rafii A, Dara&iuml; E, Haab F, et al. Body mass index and outcome of tension-free vaginal tape. Eur Urol 2003; 43:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/8\">",
"      Daneshgari F, Moore C, Frinjari H, Babineau D. Patient related risk factors for recurrent stress urinary incontinence surgery in women treated at a tertiary care center. J Urol 2006; 176:1493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/9\">",
"      Ankardal M, Heiwall B, Lausten-Thomsen N, et al. Short- and long-term results of the tension-free vaginal tape procedure in the treatment of female urinary incontinence. Acta Obstet Gynecol Scand 2006; 85:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/10\">",
"      Holmgren C, Nilsson S, Lanner L, Hellberg D. Long-term results with tension-free vaginal tape on mixed and stress urinary incontinence. Obstet Gynecol 2005; 106:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/11\">",
"      Hsiao SM, Chang TC, Lin HH. Risk factors affecting cure after mid-urethral tape procedure for female urodynamic stress incontinence: comparison of retropubic and transobturator routes. Urology 2009; 73:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/12\">",
"      Paick JS, Ku JH, Kim SW, et al. Tension-free vaginal tape procedure for the treatment of mixed urinary incontinence: significance of maximal urethral closure pressure. J Urol 2004; 172:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/13\">",
"      Duckett JR, Tamilselvi A. Effect of tension-free vaginal tape in women with a urodynamic diagnosis of idiopathic detrusor overactivity and stress incontinence. BJOG 2006; 113:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/14\">",
"      Paick JS, Ku JH, Shin JW, et al. Tension-free vaginal tape procedure for urinary incontinence with low Valsalva leak point pressure. J Urol 2004; 172:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/15\">",
"      Vierhout ME, Mulder AF. De novo detrusor instability after Burch colposuspension. Acta Obstet Gynecol Scand 1992; 71:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/16\">",
"      Anger JT, Litwin MS, Wang Q, et al. The effect of concomitant prolapse repair on sling outcomes. J Urol 2008; 180:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/17\">",
"      Brubaker L, Nygaard I, Richter HE, et al. Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence. Obstet Gynecol 2008; 112:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/18\">",
"      Chapple CR, Wein AJ, Brubaker L, et al. Stress incontinence injection therapy: what is best for our patients? Eur Urol 2005; 48:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/19\">",
"      Donnelly MJ, Powell-Morgan S, Olsen AL, Nygaard IE. Vaginal pessaries for the management of stress and mixed urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2004; 15:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/20\">",
"      Brincat C, Kenton K, Pat Fitzgerald M, Brubaker L. Sexual activity predicts continued pessary use. Am J Obstet Gynecol 2004; 191:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/21\">",
"      Clemons JL, Aguilar VC, Tillinghast TA, et al. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol 2004; 190:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/22\">",
"      Bhatia NN, Bergman A, Gunning JE. Urodynamic effects of a vaginal pessary in women with stress urinary incontinence. Am J Obstet Gynecol 1983; 147:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/23\">",
"      Maito JM, Quam ZA, Craig E, et al. Predictors of successful pessary fitting and continued use in a nurse-midwifery pessary clinic. J Midwifery Womens Health 2006; 51:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/24\">",
"      Clemons JL, Aguilar VC, Tillinghast TA, et al. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse. Am J Obstet Gynecol 2004; 190:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/25\">",
"      Leach GE, Dmochowski RR, Appell RA, et al. Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. J Urol 1997; 158:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/26\">",
"      Grady D, Brown JS, Vittinghoff E, et al. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001; 97:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/27\">",
"      Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005; 293:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/28\">",
"      Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 2007; 356:2143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/29\">",
"      Schulz JA, Nager CW, Stanton SL, Baessler K. Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections. Int Urogynecol J Pelvic Floor Dysfunct 2004; 15:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/30\">",
"      Kuhn A, Stadlmayr W, Lengsfeld D, Mueller MD. Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/31\">",
"      Keegan PE, Atiemo K, Cody J, et al. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 2007; :CD003881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/32\">",
"      Isom-Batz G, Zimmern PE. Collagen injection for female urinary incontinence after urethral or periurethral surgery. J Urol 2009; 181:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/33\">",
"      Chapple CR, Haab F, Cervigni M, et al. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Eur Urol 2005; 48:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/34\">",
"      Lightner D, Rovner E, Corcos J, et al. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology 2009; 74:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/35\">",
"      Lone F, Sultan AH, Thakar R. Long-term outcome of transurethral injection of hyaluronic acid/dextranomer (NASHA/Dx gel) for the treatment of stress urinary incontinence (SUI). Int Urogynecol J 2010; 21:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/36\">",
"      Sahai A, Thomas M, Nedas T, et al. Periurethral non-animal stabilized hyaluronic acid/dextranomer injections: efficacy and formation of granuloma/sterile abscess. Urology 2009; 74:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/37\">",
"      Lightner D, Calvosa C, Andersen R, et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 2001; 58:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/38\">",
"      Chrouser KL, Fick F, Goel A, et al. Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup. J Urol 2004; 171:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/39\">",
"      Ghoniem G, Corcos J, Comiter C, et al. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results. J Urol 2010; 183:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/40\">",
"      Mayer RD, Dmochowski RR, Appell RA, et al. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology 2007; 69:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/41\">",
"      Lai HH, Hurtado EA, Appell RA. Large urethral prolapse formation after calcium hydroxylapatite (Coaptite) injection. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/42\">",
"      Ko EY, Williams BF, Petrou SP. Bulking agent induced early urethral prolapse after distal urethrectomy. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/43\">",
"      Madjar S, Sharma AK, Waltzer WC, et al. Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol 2006; 175:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/44\">",
"      van Kerrebroeck P, ter Meulen F, Farrelly E, et al. Treatment of stress urinary incontinence: recent developments in the role of urethral injection. Urol Res 2003; 30:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/45\">",
"      Gorton E, Stanton S, Monga A, et al. Periurethral collagen injection: a long-term follow-up study. BJU Int 1999; 84:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/46\">",
"      Hurtado E, McCrery R, Appell R. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/47\">",
"      Dainer M, Hall CD, Choe J, Bhatia NN. The Burch procedure: a comprehensive review. Obstet Gynecol Surv 1999; 54:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/48\">",
"      Dmochowski RR, Blaivas JM, Gormley EA, et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol 2010; 183:1906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/49\">",
"      Pham, T, Polcari, L, Brubaker M. Surgical outcomes of secondary continence procedures. J Pelvic Medicine Surgery 2009; 12:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/50\">",
"      Huang YH, Lin AT, Chen KK, et al. High failure rate using allograft fascia lata in pubovaginal sling surgery for female stress urinary incontinence. Urology 2001; 58:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/51\">",
"      Carbone JM, Kavaler E, Hu JC, Raz S. Pubovaginal sling using cadaveric fascia and bone anchors: disappointing early results. J Urol 2001; 165:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/52\">",
"      Soergel TM, Shott S, Heit M. Poor surgical outcomes after fascia lata allograft slings. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/53\">",
"      Simsiman AJ, Powell CR, Stratford RR, Menefee SA. Suburethral sling materials: best outcome with autologous tissue. Am J Obstet Gynecol 2005; 193:2112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/54\">",
"      McBride AW, Ellerkmann RM, Bent AE, Melick CF. Comparison of long-term outcomes of autologous fascia lata slings with Suspend Tutoplast fascia lata allograft slings for stress incontinence. Am J Obstet Gynecol 2005; 192:1677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/55\">",
"      Giri SK, Hickey JP, Sil D, et al. The long-term results of pubovaginal sling surgery using acellular cross-linked porcine dermis in the treatment of urodynamic stress incontinence. J Urol 2006; 175:1788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/56\">",
"      Morgan DM, Dunn RL, Fenner DE, et al. Comparative analysis of urinary incontinence severity after autologous fascia pubovaginal sling, pubovaginal sling and tension-free vaginal tape. J Urol 2007; 177:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/57\">",
"      Abdel-Fattah M, Barrington JW, Arunkalaivanan AS. Pelvicol pubovaginal sling versus tension-free vaginal tape for treatment of urodynamic stress incontinence: a prospective randomized three-year follow-up study. Eur Urol 2004; 46:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/58\">",
"      Guerrero KL, Emery SJ, Wareham K, et al. A randomised controlled trial comparing TVT, Pelvicol and autologous fascial slings for the treatment of stress urinary incontinence in women. BJOG 2010; 117:1493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/59\">",
"      Azam U, Frazer MI, Kozman EL, et al. The tension-free vaginal tape procedure in women with previous failed stress incontinence surgery. J Urol 2001; 166:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/60\">",
"      Schraffordt Koops SE, Bisseling TM, Heintz AP, Vervest HA. The effectiveness of tension-free vaginal tape (TVT) and quality of life measured in women with previous urogynecologic surgery: analysis from The Netherlands TVT database. Am J Obstet Gynecol 2006; 195:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/61\">",
"      Tsivian A, Neuman M, Yulish E, et al. Redo midurethral synthetic sling for female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/62\">",
"      Biggs GY, Ballert KN, Rosenblum N, Nitti V. Patient-reported outcomes for tension-free vaginal tape-obturator in women treated with a previous anti-incontinence procedure. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/63\">",
"      Liapis A, Bakas P, Creatsas G. Long-term efficacy of tension-free vaginal tape in the management of stress urinary incontinence in women: efficacy at 5- and 7-year follow-up. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:1509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/64\">",
"      Stav K, Dwyer PL, Rosamilia A, et al. Repeat synthetic mid urethral sling procedure for women with recurrent stress urinary incontinence. J Urol 2010; 183:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/65\">",
"      Lo TS, Wang AC, Liang CC, et al. Treatment for unsuccessful tension-free vaginal tape operation by shortening pre-implanted tape. J Urol 2006; 175:2196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/66\">",
"      Schmid C, Bloch E, Amann E, et al. An adjustable sling in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape. Neurourol Urodyn 2010; 29:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/67\">",
"      Rutman MP, Deng DY, Shah SM, et al. Spiral sling salvage anti-incontinence surgery in female patients with a nonfunctional urethra: technique and initial results. J Urol 2006; 175:1794.",
"     </a>",
"    </li>",
"    <li>",
"     Ghoniem GM, Khater UM. Urodynamics. In: Pelvic Floor Dysfunction, Willy Davila G, Ghoniem GM, Wexner SD (Eds), Springer-Verlag, London 2006. p.35.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/69\">",
"      Rodriguez AR, Hakky T, Hoffman M, et al. Salvage spiral sling techniques: alternatives to manage disabling recurrent urinary incontinence in females. J Urol 2010; 184:2429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/70\">",
"      Cornu JN, S&egrave;be P, Peyrat L, et al. Midterm prospective evaluation of TVT-Secur reveals high failure rate. Eur Urol 2010; 58:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/71\">",
"      Basu M, Duckett J. A randomised trial of a retropubic tension-free vaginal tape versus a mini-sling for stress incontinence. BJOG 2010; 117:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/72\">",
"      Hussain M, Greenwell TJ, Venn SN, Mundy AR. The current role of the artificial urinary sphincter for the treatment of urinary incontinence. J Urol 2005; 174:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/73\">",
"      Venn SN, Greenwell TJ, Mundy AR. The long-term outcome of artificial urinary sphincters. J Urol 2000; 164:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/74\">",
"      Fichtner J. Follow-up after urinary diversion. Urol Int 1999; 63:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/23/44409/abstract/75\">",
"      Amaye-Obu FA, Drutz HP. Surgical management of recurrent stress urinary incontinence: A 12-year experience. Am J Obstet Gynecol 1999; 181:1296.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8078 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-335F5A8ACC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44409=[""].join("\n");
var outline_f43_23_44409=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      REASONS FOR FAILURE OF INITIAL SURGICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Type and severity of symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Medical history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Surgical history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pelvic examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Nonsurgical options",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Pessaries",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Medication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Surgical options",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Periurethral injection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Retropubic urethropexy (Burch colposuspension)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Bladder neck sling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Midurethral sling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Artificial urinary sphincter",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Urinary diversion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=related_link\">",
"      Clinical presentation and diagnosis of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/19/19764?source=related_link\">",
"      Patient information: Urinary incontinence treatments for women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/10/43177?source=related_link\">",
"      Stress urinary incontinence in women: Choosing a primary surgical procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=related_link\">",
"      Stress urinary incontinence in women: Retropubic midurethral slings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/39/33401?source=related_link\">",
"      Stress urinary incontinence in women: Transobturator midurethral slings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=related_link\">",
"      Treatment of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32120?source=related_link\">",
"      Urodynamic evaluation of women with incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/7/17530?source=related_link\">",
"      Vaginal pessary treatment of prolapse and incontinence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_23_44410="Paraaortic node dissection1";
var content_f43_23_44410=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51405%7EOBGYN%2F61111%7EOBGYN%2F72885%7EOBGYN%2F53957%7EOBGYN%2F65768%7EOBGYN%2F75527%7EOBGYN%2F50441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51405%7EOBGYN%2F61111%7EOBGYN%2F72885%7EOBGYN%2F53957%7EOBGYN%2F65768%7EOBGYN%2F75527%7EOBGYN%2F50441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Beginning right paraaortic node dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cephalad extent of right paraaortic node dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Completed right paraaortic node dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Beginning left paraaortic node dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Full exposure of left paraaortic node space",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Removing the cephalad portion of left paraaortic nodes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    View of aorta after paraaortic node dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44410=[""].join("\n");
var outline_f43_23_44410=null;
var title_f43_23_44411="Treatment internal radioactivity";
var content_f43_23_44411=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F54615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F54615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of selected internal radioactive contaminants",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Contaminant",
"       </td>",
"       <td class=\"subtitle1\">",
"        Treatment",
"       </td>",
"       <td class=\"subtitle1\">",
"        Principal action(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Americium",
"       </td>",
"       <td rowspan=\"5\">",
"        Wound excision,&nbsp;Ca-DTPA or Zn-DTPA",
"       </td>",
"       <td rowspan=\"5\">",
"        Chelation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Californium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plutonium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Curium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cerium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cesium",
"       </td>",
"       <td rowspan=\"3\">",
"        Prussian Blue",
"       </td>",
"       <td rowspan=\"3\">",
"        Accelerates removal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rubidium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thallium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iodine",
"       </td>",
"       <td>",
"        Potassium iodide",
"       </td>",
"       <td>",
"        Blocks thyroid uptake",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Strontium",
"       </td>",
"       <td>",
"        Aluminum antacids, ammonium chloride, calcium, barium sulfate, phosphate",
"       </td>",
"       <td>",
"        Blocks GI absorption, promotes urinary excretion and mobilization from bone&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tritium",
"       </td>",
"       <td>",
"        Fluids, diuretics",
"       </td>",
"       <td>",
"        Dilutes the isotope and promotes diuresis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uranium",
"       </td>",
"       <td>",
"        Sodium bicarbonate",
"       </td>",
"       <td>",
"        Decreases uranyl nephrotoxicity",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     DTPA: diethylenetriamine pentaacetate.",
"    </div>",
"    <div class=\"reference\">",
"     Revised from: Gusev I, Guskova AK, Mettler FA (Eds). Medical Management of Radiation Accidents, 2nd ed, CRC Press, Boca Raton, FL 2001.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44411=[""].join("\n");
var outline_f43_23_44411=null;
var title_f43_23_44412="Surg vs nonsurg Rx LBP";
var content_f43_23_44412=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F63348&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F63348&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Surgery for chronic low back pain (excluding spinal stenosis)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Intervention",
"       </td>",
"       <td class=\"subtitle1\">",
"        Population",
"       </td>",
"       <td class=\"subtitle1\">",
"        Net benefit*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Graded recommendation&sect;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interbody fusion",
"       </td>",
"       <td>",
"        Non-specific low back pain or degenerative disc disease with presumed discogenic low back pain",
"       </td>",
"       <td>",
"        Moderate versus standard physical therapy supplemented by other non-surgical therapies, no benefit versus intensive rehabilitation",
"       </td>",
"       <td>",
"        Suggested (for highly selected patient population)",
"        <strong>",
"         (2B)",
"        </strong>",
"       </td>",
"       <td>",
"        Inconsistency between trials may be related to use of different comparator interventions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Artificial disc replacement",
"       </td>",
"       <td>",
"        Non-specific low back pain or degenerative disc disease with presumed discogenic low back pain",
"       </td>",
"       <td>",
"        No evidence",
"       </td>",
"       <td>",
"        Suggest not performing",
"        <strong>",
"         (2C)",
"        </strong>",
"       </td>",
"       <td>",
"        One trial found Charite artificial disc non-inferior to fusion and one trial found Prodisc-L artificial disc superior to fusion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Standard open discectomy or microdiscectomy",
"       </td>",
"       <td>",
"        Lumbar disc prolapse with radiculopathy",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"       <td>",
"        Suggested",
"        <strong>",
"         (2B)",
"        </strong>",
"       </td>",
"       <td>",
"        <p>",
"         In largest trial, 40 to 55 percent crossover in both arms; on-treatment analysis consistent with other trials.",
"        </p>",
"        <p>",
"         Benefits associated with surgery attenuated with longer-term follow-up.",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Based on evidence showing medication is more effective than placebo, and/or evidence showing medication is at least as effective as other medications or interventions thought to be effective, for one or more of the following outcomes: pain, functional status, or work status. Versus placebo, small benefit defined as 5-10 points on a 100-point Visual Analogue Scale (VAS) for pain (or equivalent), 1-2 points on the Roland Morris Disability Questionnaire (RDQ), 10-20 points on the Oswestry Disability Index (ODI), or a standardized mean difference (SMD) of 0.2-0.5. Moderate benefit defined as 10-20 points on a VAS for pain, 2-5 points on the RDQ, 10-20 points on the ODI, or a SMD of 0.5-0.8. Large benefit defined as &gt;20 points on a 100 point VAS for pain; &gt;5 points on the RDQ, &gt;20 points on the ODI, or a SMD of &gt;0.8.",
"     <br>",
"      &sect; Grading:",
"      <br>",
"       <strong>",
"        1A",
"       </strong>",
"       - Strong recommendation. High quality evidence. Strong recommendation, can apply to most patients in most circumstances without reservation.",
"       <br>",
"        <strong>",
"         1B",
"        </strong>",
"        - Strong recommendation. Moderate quality evidence. Strong recommendation, likely to apply to most patients.",
"        <br>",
"         <strong>",
"          1C",
"         </strong>",
"         - Strong recommendation. Low quality evidence. Relatively strong recommendation; might change when higher quality evidence becomes available.",
"         <br>",
"          <strong>",
"           2A",
"          </strong>",
"          - Weak recommendation. High quality evidence. Weak recommendation, best action may differ depending on circumstances or patients or societal values.",
"          <br>",
"           <strong>",
"            2B",
"           </strong>",
"           - Weak recommendation. Moderate quality evidence. Weak recommendation, alternative approaches likely to be better for some patients under some circumstances.",
"           <br>",
"            <strong>",
"             2C",
"            </strong>",
"            - Weak recommendation. Low quality evidence. Very weak recommendation; other alternatives may be equally reasonable.",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44412=[""].join("\n");
var outline_f43_23_44412=null;
var title_f43_23_44413="Contents: Hospital neurology";
var content_f43_23_44413=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?2/63/3070\">",
"       Hospital Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Hospital neurology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Hospital neurology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/1/36889\">",
"           Acute toxic-metabolic encephalopathy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/20/26952\">",
"           Cardiac complications of stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/10/39081\">",
"           Diagnosis of delirium and confusional states",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/37/36439\">",
"           Differential diagnosis of transient ischemic attack and stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/51/34615\">",
"           Evaluation of headache in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/29/33242\">",
"           Initial assessment and management of acute stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/11/10426\">",
"           Initial evaluation and management of transient ischemic attack and minor stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/4/31818\">",
"           Initial treatment of epilepsy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/6/19561\">",
"           Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/12/17610\">",
"           Medical complications of stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/47/3834\">",
"           Neurologic complications of cardiac surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/47/28410\">",
"           Overview of the evaluation of stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/9/10394\">",
"           Perioperative care of the surgical patient with neurologic disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/33/28185\">",
"           Prevention and treatment of delirium and confusional states",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/11/19642\">",
"           Status epilepticus in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/9/28825\">",
"           Stupor and coma in adults",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-5FFE628A51-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f43_23_44413=[""].join("\n");
var outline_f43_23_44413=null;
var title_f43_23_44414="Thin blood smear 2A with answer";
var content_f43_23_44414=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F61406&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F61406&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blood smear of falciparum malaria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 395px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Giemsa stained thin smear of blood (x1000) shows an erythrocyte with multiple ring trophozoites of Plasmodium falciparum (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Maryann Waldron.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44414=[""].join("\n");
var outline_f43_23_44414=null;
var title_f43_23_44415="Undescended testicle";
var content_f43_23_44415=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72440&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72440&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Undescended testicle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 279px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Laparoscopic view of intra-abdominal right-sided undescended testicle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christopher S Cooper, MD and Steven G Docimo, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_23_44415=[""].join("\n");
var outline_f43_23_44415=null;
